Erythropoietin treatment reduces inflammatory reaction and improves liver regeneration after major hepatic resection in cirrhotic rat models (Unbekannt)
- Neue Suche nach: Suh, S.
- Neue Suche nach: Choi, Y.-S.
- Neue Suche nach: Suh, S.
- Neue Suche nach: Choi, Y.-S.
In:
Journal of hepatology
;
66
, 1
;
S579
;
2017
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Erythropoietin treatment reduces inflammatory reaction and improves liver regeneration after major hepatic resection in cirrhotic rat models
-
Beteiligte:Suh, S. ( Autor:in ) / Choi, Y.-S. ( Autor:in )
-
Erschienen in:Journal of hepatology ; 66, 1 ; S579
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2017
-
Format / Umfang:S579
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Unbekannt
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 66, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
From the Editor’s desk...Moreau, Richard / Bataller, Ramon / Berg, Thomas / Zucman-Rossi, Jessica / Jalan, Rajiv et al. | 2017
- 5
-
Bad memories from the gut may cause nightmares for the bile ductsFickert, Peter et al. | 2017
- 8
-
Does the liver accelerate ageing: Talking muscles and liver?Trenell, Michael I. / Marchesini, Giulio et al. | 2017
- 11
-
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyFung, Scott / Kwan, Peter / Fabri, Milotka / Horban, Andrzej / Pelemis, Mijomir / Hann, Hie-Won / Gurel, Selim / Caruntu, Florin A. / Flaherty, John F. / Massetto, Benedetta et al. | 2017
- 19
-
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationInnes, Hamish / McDonald, Scott / Hayes, Peter / Dillon, John F. / Allen, Sam / Goldberg, David / Mills, Peter R. / Barclay, Stephen T. / Wilks, David / Valerio, Heather et al. | 2017
- 28
-
High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver diseaseHedegaard, Ditte L. / Tully, Damien C. / Rowe, Ian A. / Reynolds, Gary M. / Bean, David J. / Hu, Ke / Davis, Christopher / Wilhelm, Annika / Ogilvie, Colin B. / Power, Karen A. et al. | 2017
- 39
-
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patientsPol, Stanislas / Bourliere, Marc / Lucier, Sandy / Hezode, Christophe / Dorival, Céline / Larrey, Dominique / Bronowicki, Jean-Pierre / Ledinghen, Victor D.E. / Zoulim, Fabien / Tran, Albert et al. | 2017
- 48
-
Time trends of chronic HBV infection over prior decades – A global analysisOtt, Jördis J. / Horn, Johannes / Krause, Gérard / Mikolajczyk, Rafael T. et al. | 2017
- 55
-
Continuous de novo generation of spatially segregated hepatitis C virus replication organelles revealed by pulse-chase imagingWang, Hongliang / Tai, Andrew W. et al. | 2017
- 67
-
Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCCHocquelet, Arnaud / Aubé, Christophe / Rode, Agnès / Cartier, Victoire / Sutter, Olivier / Manichon, Anne Frederique / Boursier, Jérome / N’kontchou, Gisèle / Merle, Philippe / Blanc, Jean-Frédéric et al. | 2017
- 75
-
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine modelLi, Guangfu / Liu, Dai / Cooper, Timothy K. / Kimchi, Eric T. / Qi, Xiaoqiang / Avella, Diego M. / Li, Ningfei / Yang, Qing X. / Kester, Mark / Rountree, C. Bart et al. | 2017
- 86
-
Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injuryGuixé-Muntet, Sergi / de Mesquita, Fernanda Cristina / Vila, Sergi / Hernández-Gea, Virginia / Peralta, Carmen / García-Pagán, Juan Carlos / Bosch, Jaime / Gracia-Sancho, Jordi et al. | 2017
- 95
-
Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injuryFuchs, Claudia D. / Paumgartner, Gustav / Wahlström, Annika / Schwabl, Philipp / Reiberger, Thomas / Leditznig, Nadja / Stojakovic, Tatjana / Rohr-Udilova, Nataliya / Chiba, Peter / Marschall, Hanns-Ulrich et al. | 2017
- 102
-
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophagesRaggi, Chiara / Correnti, Margherita / Sica, Antonio / Andersen, Jesper B. / Cardinale, Vincenzo / Alvaro, Domenico / Chiorino, Giovanna / Forti, Elisa / Glaser, Shannon / Alpini, Gianfranco et al. | 2017
- 116
-
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel diseaseHenriksen, Eva Kristine Klemsdal / Jørgensen, Kristin Kaasen / Kaveh, Fatemeh / Holm, Kristian / Hamm, David / Olweus, Johanna / Melum, Espen / Chung, Brian K. / Eide, Tor J. / Lundin, Knut E.A. et al. | 2017
- 123
-
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosisKoo, Bo Kyung / Kim, Donghee / Joo, Sae Kyung / Kim, Jung Ho / Chang, Mee Soo / Kim, Byeong Gwan / Lee, Kook Lae / Kim, Won et al. | 2017
- 132
-
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver diseaseGariani, Karim / Ryu, Dongryeol / Menzies, Keir J. / Yi, Hyon-Seung / Stein, Sokrates / Zhang, Hongbo / Perino, Alessia / Lemos, Vera / Katsyuba, Elena / Jha, Pooja et al. | 2017
- 142
-
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic reviewHashida, Ryuki / Kawaguchi, Takumi / Bekki, Masafumi / Omoto, Masayuki / Matsuse, Hiroo / Nago, Takeshi / Takano, Yoshio / Ueno, Takato / Koga, Hironori / George, Jacob et al. | 2017
- 153
-
EASL Recommendations on Treatment of Hepatitis C 2016| 2017
- 195
-
The genetics of alcohol dependence and alcohol-related liver diseaseStickel, Felix / Moreno, Christophe / Hampe, Jochen / Morgan, Marsha Y. et al. | 2017
- 212
-
Liver sinusoidal endothelial cells: Physiology and role in liver diseasesPoisson, Johanne / Lemoinne, Sara / Boulanger, Chantal / Durand, François / Moreau, Richard / Valla, Dominique / Rautou, Pierre-Emmanuel et al. | 2017
- 228
-
Determinants of hepatic effector CD8+ T cell dynamicsBenechet, Alexandre Pierre / Iannacone, Matteo et al. | 2017
- 234
-
Molecular targets for HCC and future treatmentsAllaire, Manon / Nault, Jean-Charles et al. | 2017
- 236
-
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?Zavaglia, Claudio / Okolicsanyi, Stefano / Cesarini, Lucia / Mazzarelli, Chiara / Pontecorvi, Valerio / Ciaccio, Antonio / Strazzabosco, Mario / Belli, Luca Saverio et al. | 2017
- 237
-
Hepatitis C testing in U.S. veterans born 1945–1965: An updateRoss, David B. / Belperio, Pamela S. / Chartier, Maggie / Backus, Lisa I. et al. | 2017
- 239
-
Reply to: “Hepatitis C testing in U.S. veterans born 1945–1965: An update”Justice, Amy C. / Esserman, Denise / Sarkar, Souvik / Levin, Forrest L. / Skanderson, Melissa / Lim, Joseph K. et al. | 2017
- 240
-
The anti-inflammatory role of propranolol in cirrhosis: Preventing the inflammatory exhaustion?Brito-Azevedo, Anderson / Perez, Renata de Mello / Coelho, Henrique Sérgio Moraes / Fernandes, Eduardo de Souza Martins / Castiglione, Raquel Carvalho / Villela-Nogueira, Cristiane Alves / Bouskela, Eliete et al. | 2017
- 242
-
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infectionvan der Valk, Marc / Zaaijer, Hans L. / Kater, Arnon P. / Schinkel, Janke et al. | 2017
- 243
-
The association between sarcopenia and non-alcoholic fatty liver diseaseHu, Yi-Bing / Chen, Ze / Fu, Rong-Quan et al. | 2017
- 244
-
Reply to: “The association between sarcopenia and non-alcoholic fatty liver disease”Koo, Bo Kyung / Kim, Donghee / Joo, Sae Kyung / Kim, Jung Ho / Chang, Mee Soo / Kim, Byeong Gwan / Lee, Kook Lae / Kim, Won et al. | 2017
- 246
-
Are we still searching for the fifth element of MELD?Thevenot, Thierry / Weil, Delphine / Cervoni, Jean-Paul / Villamil, Federico G. / Di Martino, Vincent et al. | 2017
- 247
-
Reply to: “Are we still searching for the fifth element of MELD?”Solà, Elsa / Kerbert, Annarein / Coenraad, Minneke / Ginès, Pere et al. | 2017
- 248
-
Procoagulant imbalance in patients with non-alcoholic fatty liver diseaseTripodi, Armando / Fracanzani, Anna L. / Chantarangkul, Veena / Primignani, Massimo / Fargion, Silvia et al. | 2017
- 250
-
Reply to: “Procoagulant imbalance in patients with non-alcoholic fatty liver disease”Potze, Wilma / Sanyal, Arun J. / Lisman, Ton et al. | 2017
- 252
-
Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”Löffler, Markus W. / Chandran, P. Anoop / Laske, Karoline / Schroeder, Christopher / Bonzheim, Irina / Walzer, Mathias / Hilke, Franz J. / Trautwein, Nico / Kowalewski, Daniel J. / Schuster, Heiko et al. | 2017
- 255
-
Acknowledgement to our reviewers| 2017
- S1
-
Multicenter randomized trial comparing short-term stenting versus balloon dilatation for dominant strictures in primary sclerosing cholangitisPonsioen, C. / Arnelo, U. / Bergquist, A. / Rauws, E. / Paulsen, V. / Cantu, P. / Parzanese, I. / de Vries, E. / Said, K. / Chazouilleres, O. et al. | 2017
- S2
-
Changes in fibrosis, but not the NAFLD Activity Score (NAS), are associated with disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosisSanyal, A. / Harrison, S. / Ratziu, V. / Abdelmalek, M. / Diehl, A. / Caldwell, S. / Shiffman, M. / Aguilar, R. / Jia, C. / McColgan, B. et al. | 2017
- S3
-
EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosisForns, X. / Lee, S. / Valdes, J. / Lens, S. / Ghalib, R. / Aguilar, H. / Felizarta, F. / Hassanein, T. / Hinrichsen, H. / Rincon, D. et al. | 2017
- S4
-
Common variation near glial-derived neurotrophic factor is associated with progression of hepatic collagen content in a genome-wide association study of liver fibrosis phenotypes in patients with primary sclerosing cholangitisShea, P. / Hirschfield, G. / Shiffman, M. / McColgan, B. / Goodman, Z. / Myers, R. / Subramanian, M. / Eksteen, B. / Janssen, H. / Bowlus, C. et al. | 2017
- S5
-
Improvement of gene therapy for Wilson’s diseaseMurillo-Sauca, O. / Moreno-Luqui, D. / Gazquez, C. / Navarro-Blasco, I. / Hernández-Alcoceba, R. / González-Aseguinolaza, G. et al. | 2017
- S6
-
Ileo-anal pouch anastomosis negatively impacts graft survival following liver transplantation for primary sclerosing cholangitisTrivedi, P.J. / Reece, J. / Laing, R.W. / Slaney, E. / Cooney, R. / Iqbal, T. / Gunson, B. / Thompson, F. / Mueisan, P. / Hirschfield, G.M. et al. | 2017
- S7
-
Comparison of continuous plasma diafiltration therapy and conventional therapy in critical patients with acute liver failureNishikawa, M. / Taniguchi, T. / Okajima, M. / Kaneko, S. et al. | 2017
- S8
-
Neutrophil dysfunction is potentially predictive of mortality and multi-organ failure in acute decompensation and acute-on-chronic liver failure patientsLu, H. / Macnaughtan, J. / Sawhney, R. / Jones, H. / Holland-Fischer, P. / Ghasemi, M. / Wright, G. / Davies, N. / Mookerjee, R.P. / Jalan, R. et al. | 2017
- S9
-
The level of hepatocyte death biomarkers correlates with severity and predicts early mortality in patients with acute decompensation with or without acute-on-chronic liver failureCao, Z. / Chen, L. / Wang, Y. / Yan, L. / Liu, Y. / Liu, K. / Li, F. / Xiang, X. / Tang, W. / Xie, J. et al. | 2017
- S10
-
New diagnostic algorithm of acute kidney injury in cirrhosis that includes categorization of stage 1 and assessment of urine NGAL. Relevance for the differential diagnosis and clinical outcomesHuelin, P. / Elia, C. / Solà, E. / Solé, C. / Moreira, R. / Carol, M. / Fabrelles, N. / Risso, À. / Albertos, S. / Glavin, E. et al. | 2017
- S12
-
Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trialPinyol, R. / Montal, R. / Takayama, T. / Chau, G.-Y. / Mazzaferro, V. / Roayaie, S. / Lee, H.C. / Poon, R.T.-P. / Kokudo, N. / Zhang, Z. et al. | 2017
- S13
-
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicentre cohort studyVitale, A. / Farinati, F. / Huo, T.-L. / Trevisani, F. / Giannini, E.G. / Piscaglia, F. / Cillo, U. et al. | 2017
- S14
-
Development and validation of a survival calculator for hepatocellular carcinoma patients undergoing liver transplantation: the Metroticket 2.0 modelSposito, Carlo / Cucchetti, Alessandro / Zhou, Jian / Pinna, Antonio D. / De Carlis, Luciano / Bongini, Marco / Cescon, Matteo / Fan, Jia / Di Sandro, Stefano / Yi-feng, He et al. | 2017
- S15
-
Risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance – a territory-wide analysis of 5181 patientsChan, H.L.Y. / Yip, T.C.F. / Wong, V.W.S. / Tse, Y.K. / Wong, G.L.H. et al. | 2017
- S16
-
YH25724, a novel long-acting GLP-1/FGF21 dual agonist lowers both non-alcoholic fatty liver disease activity score and fibrosis stage in a diet-induced obese mouse model of biopsy-confirmed non-alcoholic steatohepatitisHong, H.N. / Kim, J.H. / Choi, H.H. / Kim, D. / Kim, T.W. / Tølbøl, K.S. / Feigh, M. / Illemann, M. / Rigbolt, K. / Vrang, N. et al. | 2017
- S18
-
FXR agonists with sustained systemic rather than transient intestinal exposure are more efficacious in a diet-induced obese non-alcoholic steatohepatitis mouse modelWagner, B. / Brigham, D. / Lee, K.-J. / Ortiz, A. / Lu, N. / Qian, J. / Douglas, K. / Nagasawa, J. / Govek, S. / Feigh, M. et al. | 2017
- S19
-
Combination of an ASK1 inhibitor and FXR agonist increases efficacy in a mouse model of non-alcoholic steatohepatitisLiles, J.T. / Zagorska, A. / Hollenback, D. / Budas, G.R. / Liu, H. / Liu, K. / Brockett, R. / Shauf, A. / Tumas, D. / Breckenridge, D.G. et al. | 2017
- S20
-
HCV eradication reduces the occurrence of major adverse cardiovascular events in hepatitis C cirrhotic patients: data from the prospective ANRS CO12 CirVir cohortCacoub, P. / Nahon, P. / Layese, R. / Bourcier, V. / Cagnot, C. / Marcellin, P. / Guyader, D. / Pol, S. / Larrey, D. / Roudot-Thoraval, F. et al. | 2017
- S21
-
Identifying residual risk of hepatocellular carcinoma following hepatitis C virus eradication in compensated cirrhosis: decision-tree and random forest models developed in the French multicenter prospective ANRS CO12 CirVir cohortAudureau, E. / Bourcier, V. / Layese, R. / Cagnot, C. / Marcellin, P. / Guyader, D. / Pol, S. / Larrey, D. / Roudot-Thoraval, F. / Nahon, P. et al. | 2017
- S22
-
Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide CohortInnes, H. / Barclay, S.T. / Hayes, P.C. / Fraser, A. / Dillon, J.F. / Stanley, A. / Bathgate, A. / McDonald, S. / Goldberg, D. / Valerio, H. et al. | 2017
- S23
-
Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antiviralsCalvaruso, V. / Cabibbo, G. / Cacciola, I. / Petta, S. / Madonia, S. / Bellia, A. / Stefano, M.D. / Giannitrapani, L. / Tinè, F. / Magro, A. et al. | 2017
- S24
-
Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjectsTanwandee, T. / Chatsiricharoenkul, S. / Thongsawat, S. / Sukeepaisarnjaroen, W. / Tangkijvanich, P. / Komolmit, P. / Avihingsanon, A. / Piratvisuth, T. / Sunthi, P. / Mahasanprasert, T. et al. | 2017
- S25
-
A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96Brunetto, M. / Lim, Y.S. / Gane, E. / Seto, W.K. / Osipenko, M. / Ahn, S.H. / Janssen, H.L. / Shukla, A. / Chuang, W.L. / Trinh, H. et al. | 2017
- S26
-
A phase1 study evaluating anti-PD-1 treatment with or without GS-4774 in HBeAg negative chronic hepatitis B patientsGane, E. / Gaggar, A. / Nguyen, A.H. / Subramanian, G.M. / McHutchison, J.G. / Schwabe, C. / Dunbar, R. et al. | 2017
- S27
-
Multiple dose study of GLS4JHS, interfering with the assembly of hepatitis B virus core particles, in patients infected with hepatitis B virusDing, Y. / Zhang, H. / Niu, J. / Chen, H. / Liu, C. / Li, X. / Wang, F. et al. | 2017
- S28
-
Modifications of virus-specific and total B cell populations by hepatitis B virus infectionSalimzadeh, L. / Bert, N.L. / Gill, U.S. / Kennedy, P.T. / Samuel, D. / Novikov, N. / Pflanz, S. / Frey, C.R. / Bertoletti, A. et al. | 2017
- S29
-
Hepatitis B virus-specific T cell receptors with high functional avidity redirect T cells to eliminate HBVWisskirchen, K. / Kah, J. / Metzger, K. / Weigand, L. / Uckert, W. / Schiemann, M. / Volz, T. / Krackhardt, A. / Dandri, M. / Protzer, U. et al. | 2017
- S33
-
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 studyYurdaydin, C. / Idilman, R. / Keskin, O. / Kalkan, C. / Karakaya, M.F. / Caliskan, A. / Yurdcu, E. / Karatayli, S.C. / Bozdayi, M. / Koh, C. et al. | 2017
- S34
-
Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 studySangro, B. / Yau, T. / Hsu, C. / Kudo, M. / Crocenzi, T.S. / Choo, S.-P. / Meyer, T. / Welling, T.H. / Yeo, W. / Chopra, A. et al. | 2017
- S35
-
Mucosal-associated invariant T cells are significantly decreased and exhausted in patients with autoimmune liver disease, but promote primary hepatic stellate cell proliferationSchölzel, K. / Rombouts, K. / Rosselli, M. / Saffioti, F. / Roccarina, D. / Marshall, A. / Thorburn, D. / Pinzani, M. et al. | 2017
- S36
-
Inhibition of IL-1b/STAT3/β-catenin-dependent stimulation of the CXCL10/CXCR3 axis prevents macrophage recruitment and progression of the disease in Pkhd1del4/del4 mice, a model of congenital hepatic fibrosisKaffe, E. / Pellegrino, F. / Mariotti, V. / Fabris, L. / Cadamuro, M. / Amenduni, M. / Fiorotto, R. / Strazzabosco, M. / Spirli, C. et al. | 2017
- S37
-
C5a receptor blocking in TLR4 mutant C3H/HeJ mouse extensively hampers the liver regeneration processFaiyaz, R. / Mallard, B. / Muhamad, M. / Leonard, N. / Wheatley, A. et al. | 2017
- S39
-
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European studyBelli, L.S. / Berenguer, M. / Cortesi, P.A. / Facchetti, R. / Strazzabosco, M. / Perricone, G. / Rockenschaub, S.-R. / Martini, S. / Morelli, C. / Donato, F. et al. | 2017
- S40
-
Changes in brain integrity underlying cognitive and functional recovery following liver transplantation plateaus after six monthsAhluwalia, V. / Wade, J. / Steinberg, J.L. / White, M. / Fagan, A. / Ganapathy, D. / Moeller, F.G. / Bajaj, J.S. et al. | 2017
- S42
-
Successful maintenance of direct converted hepatocyte–like cells by 3D bio printingWoo, J. / Choi, D. et al. | 2017
- S43
-
Visualizing hepatocellular amino acid kinetics through mass spectrometry imaging of stable isotopesArts, M. / Soons, Z. / Dubois, L.J. / Pierzchalski, K.A. / Ellis, S.R. / Balluff, B. / Eijkel, G.B. / Cramer, T. / Lieuwes, N. / Agten, S.M. et al. | 2017
- S44
-
The bile acid receptor TGR5 regulates paracellular permeability and protects the liver through an impact on the tight junction protein JAM-AMerlen, G. / Ursic-Bedoya, J. / Kahale, N. / Simerabet, H. / Doignon, I. / Tanfin, Z. / Péan, N. / Gautherot, J. / Ullmer, C. / Humbert, L. et al. | 2017
- S45
-
Hepatocyte polyploidy in response to loss of Cdk1 induces chronic hepatic inflammation and progenitor cell activationDewhurst, M. / Hul, N.V. / Caldez, M. / Kaldis, P. et al. | 2017
- S46
-
Simvastatin ameliorates the sinusoidal microcirculatory phenotype, fibrosis and portal hypertension in aged cirrhotic ratsMaeso-Diaz, R. / Ortega-Ribera, M. / Fernandez-Iglesias, A. / Muñoz, L. / Vila, S. / Albillos, A. / Garcia-Pagan, J.C. / Bosch, J. / Gracia-Sancho, J. et al. | 2017
- S47
-
Small-diameter covered stents do not affect efficacy but reduce hepatic encephalopathy in transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhosisWang, Q. / He, C. / Yin, Z. / Bai, M. / Wang, Z. / Guo, W. / Cai, H. / Xia, J. / Chen, H. / Lv, Y. et al. | 2017
- S48
-
Novel diameter controlled expansion TIPS (Viatorr CX®)graft reduces readmission compared to regular covered TIPS graft and bare metal graftPraktiknjo, M. / Lehmann, J. / Fischer, S. / Strassburg, C.P. / Meyer, C. / Trebicka, J. et al. | 2017
- S51
-
Treatment with selonsertib, an inhibitor of apoptosis signal-regulating kinase 1, hepatic phospho-p38 expression and markers of hepatocellular apoptosis and necrosis in patients with nonalcoholic steatohepatitisDiehl, A.M. / French, D. / Xu, R. / Loomba, R. / Lawitz, E. / Freilich, B. / Shiffman, M.L. / Chalasani, N. / Hameed, B. / Caldwell, S. et al. | 2017
- S53
-
Methylation signatures in blood show accelerated epigenetic aging in patients with non-alcoholic steatohepatitis compared to healthy controlsLoomba, R. / Gindin, Y. / Jiang, Z. / Lawitz, E. / Djedjos, C.S. / Caldwell, S. / Xu, R. / Gong, D. / Myers, R.P. / Subramanian, G.M. et al. | 2017
- S54
-
Real world experience with elbasvir/grazoprevir in the Veterans Affairs Healthcare SystemKramer, J.R. / Puenpatom, A. / Erickson, K. / Cao, Y. / El-Serag, H. / Kanwal, F. et al. | 2017
- S55
-
Sustained virological response for 94% of people treated with low-cost, legally imported generic direct acting antivirals for hepatitis C: analysis of 1087 patients in 4 treatment programmesFreeman, J. / Khwairakpam, G. / Dragunova, J. / Golovin, S. / Wang, J. / Hill, A. / Houghton-Price, V. / Smith, R. / Korologou-Linden, R. / Jefferys, G. et al. | 2017
- S56
-
Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in TaiwanLiu, C.-J. / Chuang, W.-L. / Sheen, I.-S. / Wang, H.-Y. / Chen, C.-Y. / Tseng, K.-C. / Chang, T.-T. / Massetto, B. / Yang, J. / Camus, G. et al. | 2017
- S56
-
Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 StudySaadoun, D. / Pol, S. / Ferfar, Y. / Hezode, C. / Ahmed, S.N.S. / Alric, L. / de Saint Martin, L. / Bouyer, A.S. / Musset, L. / Poynard, T. et al. | 2017
- S57
-
Ledipasvir/sofosbuvir ± ribavirin for 12 or 24 weeks is safe and effective in children 6–11 years old with chronic hepatitis C infectionMurray, K.F. / Balistreri, W. / Bansal, S. / Whitworth, S. / Evans, H. / Gonzalez-Peralta, R.P. / Wen, J. / Massetto, B. / Kersey, K. / Zhu, Y. et al. | 2017
- S58
-
Hepatitis E virus infection and acute non-traumatic neurological injury: an international prospective pilot studyWebb, G.W. / van Eijk, J.J.J. / Cintas, P. / Norton, B. / Madden, R.G. / Jones, C. / Hunter, J.G. / Devooght-Johnson, N. / Pique, J. / Woolson, K. et al. | 2017
- S59
-
RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus dispensable of interferon productionXu, L. / Wang, W. / Li, Y. / Zhou, X. / Yin, Y. / Wang, Y. / de Man, R.A. / Van Der Laan, L.J.W. / Huang, F. / Kamar, N. et al. | 2017
- S61
-
Blood-borne HEV transmission: first experience with global HEV screening at a tertiary centerWesthölter, D. / Hiller, J. / Denzer, U. / Peine, S. / Polywka, S. / Lohse, A.W. / Pischke, S. / Lütgehetmann, M. et al. | 2017
- S63
-
Gut microbiota are associated with impaired brain recovery after liver transplantBajaj, J.S. / Fagan, A. / Wade, J. / Gavis, E.A. / White, M. / Ganapathy, D. / Heuman, D. / Sikaroodi, M. / Fuchs, M. / John, B. et al. | 2017
- S64
-
The restoration of a healthy intestinal microbiota by fecal transplantation normalizes portal hypertension and endothelial dysfunction in a rat model of diet-induced non-alcoholic steatohepatitisGarcía-Lezana, T. / Martell, M. / Raurell, I. / Bravo, M. / Torres-Arauz, M. / Salcedo, M.T. / Manichanh, C. / Genescà, J. / Augustin, S. et al. | 2017
- S66
-
FibroScan-based score to identify patients with non-alcoholic steatohepatitis: development in a multi-centric British cohort and validation in a large American cohortSasso, M. / Harrison, S.A. / Eddowes, P.J. / Anstee, Q.M. / Guha, I.N. / Sherridan, D. / Tsochatzis, E. / Cobbold, J.F. / Allison, M. / Fournier, C. et al. | 2017
- S67
-
Reliability criteria for the diagnosis of fatty liver using controlled attenuation parameter by transient elastography – A multicentre study of 754 patientsWong, V.W.-S. / Petta, S. / Hiriart, J.-B. / Cammà, C. / Wong, G.L.-H. / Marra, F. / Vergniol, J. / Chan, A.W.-H. / Di Marco, V. / Merrouche, W. et al. | 2017
- S68
-
Simple non-invasive fibrosis scores identify patients with non-alcoholic fatty liver disease who progress to advanced fibrosis/cirrhosis:evidence from a large cohort of patients with sequential liver biopsiesMcpherson, S. / Pais, R. / Valenti, L. / Schattenberg, J.M. / Dufour, J.-F. / Tsochatzis, E. / Francque, S. / Hardy, T. / Boyle, M. / Tiniakos, D. et al. | 2017
- S69
-
Comparison of clinical prediction rules for detection of cirrhosis in non-alcoholic fatty liver disease: a multicenter, international, collaborative study- NASH CRN (USA) and Newcastle (UK) CohortBrandman, D. / Boyle, M. / McPherson, S. / Van Natta, M. / Sanyal, A. / Kowdley, K. / Tetri, B. / Chalassani, N. / Abdelmalek, M. / Terrault, N.A. et al. | 2017
- S70
-
Outcomes of treatment for hepatitis C virus infection in the prison settingMcDonald, L. / Cragie, A. / Schulberg, J. / Scarmozzino, J. / Papaluca, T. / Stoove, M. / Howell, J. / Doyle, J. / Iser, D. / Thompson, A. et al. | 2017
- S71
-
Treatment cascade of hepatitis B and C in general, migrant and Roma populationsTouloumi, G. / Karakosta, A. / Kaskafetou, S. / Petraki, I. / Anagnostou, O. / Gavana, M. / Papatheodoridis, G. / Kalpourtzi, A. / Mimikou, T. / Antypas, T. et al. | 2017
- S72
-
HIV/HCV-coinfected cirrhotic patients are no longer at higher risk of hepatocellular carcinoma or end-stage liver disease as compared to HCV-monoinfected patients (ANRS CO12 CirVir and ANRS CO13 HEPAVIH cohorts)Salmon, D. / Nahon, P. / Layese, R. / Bourcier, V. / Audureau, E. / Gilbert, C. / Esterle, L. / Dabis, F. / Wittkop, L. / Roudot-Thoraval, F. et al. | 2017
- S74
-
Molecular effects of the soluble guanylyl cyclase stimulator riociguat on biliary cirrhosis and effects on transaminases in patientsSchwabl, P. / Brusilovskaya, K. / Königshofer, P. / Supper, P. / Bauer, D. / Riedl, F. / Rohr-Udilova, N. / Hayden, H. / Aschauer, S. / Bonderman, D. et al. | 2017
- S75
-
The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitisReuveni, D. / Leung, P. / Vig, P. / Shibolet, O. / Gershwin, E.M. / Zigmond, E. et al. | 2017
- S76
-
Development of novel epigenetic inhibitors for the treatment of hepatocellular carcinomaBárcena-Varela, M. / Oyarzabal, J. / Banales, J.M. / Prieto, J. / Alvarez-Asiain, L. / Prosper, F. / Berasain, C. / Avila, M.A. / Fernandez-Barrena, M.G. et al. | 2017
- S77
-
Hepatic LGR5 stem cells contribute to liver carcinogenesisCao, W. / Li, M. / Liu, P. / Liu, J. / Bolkestein, M. / Chen, K. / Van Der Laan, L.J.W. / Sprengers, D. / Metselaar, H.J. / Kwekkeboom, J. et al. | 2017
- S78
-
Diabetes augments obesity in accelerating liver tumour development: role of oxidative stress-induced JNK signalling and DNA damage responseArfianti, E. / Barn, V. / Pok, S. / Larter, C.Z. / Teoh, N.C. / Farrell, G.C. et al. | 2017
- S79
-
Efficacy of grannulocyte colony stimulating factor in the management of steroid non-responsive severe alcoholic hepatitis – A double blind randomised control trialShasthry, S.M. / Sharma, M. / Sarin, S. et al. | 2017
- S80
-
Comparison of cytokine profiles in idiosyncratic drug-induced liver injury, acute non-drug-induced hepatitis and controlsStephens, C. / Sanjuan-Jiménez, R. / Sanabria-Cabrera, J.A. / Battikhi, B. / Ortega-Alonso, A. / Robles-Díaz, M. / Jiménez-Pérez, M. / Medina-Cáliz, I. / Ruiz-Cabello, F. / Lucena, M.I. et al. | 2017
- S82
-
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesDi Maio, V.C. / Cento, V. / Lenci, I. / Aragri, M. / Barbaliscia, S. / Francioso, S. / Paolucci, S. / Melis, M. / Verucchi, G. / Coppola, N. et al. | 2017
- S83
-
MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failurePoordad, F. / Pol, S. / Asatryan, A. / Buti, M. / Shaw, D. / Hézode, C. / Lalezari, J. / Felizarta, F. / Reindollar, R.W. / Gordon, S.C. et al. | 2017
- S84
-
Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week courseCheung, M.C. / Filipe, A. / Walker, A. / Mutimer, D.J. / Agarwal, K. / Aldersley, M. / MacDonald, D. / Khakoo, S. / McLauchlan, J. / Foster, G.R. et al. | 2017
- S85
-
SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinomaVilgrain, V. / Bouattour, M. / Sibert, A. / Lebtahi, R. / Ronot, M. / Pageaux, G.-P. / Guiu, B. / Barraud, H. / Silvain, C. / Gérolami, R. et al. | 2017
- S86
-
Etiology, time frame and spectrum of decompensation in 6236 patients of cirrhosis liver across Asia: a multinational study from APASL ACLF Research Consortium (AARC)Choudhury, A. / Sharma, M.K. / Sharma, B.C. / Maiwal, R. / Pamecha, V. / Moreau, R. / Chawla, Y.K. / Duseja, A. / Mahtab, M.A. / Rahman, S. et al. | 2017
- S87
-
Interaction between alcohol use and metabolic components in predicting severe liver disease in the general population – a decade follow-up of a nationally representative cohortÅberg, F. / Helenius-Hietala, J. / Puukka, P. / Färkkilä, M. / Jula, A. et al. | 2017
- S88
-
Safety and efficacy of besifovir in treatment-naïve chronic hepatitis B virus infection: a randomized, double-blind, double dummy, phase 3 studyAhn, S.H. / Kim, W. / Jung, Y.K. / Yang, J.M. / Jang, J.Y. / Kweon, Y.O. / Cho, Y.K. / Kim, Y.J. / Hong, G.Y. / Kim, D.J. et al. | 2017
- S89
-
BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 studySanyal, A. / Charles, E.D. / Neuschwander-Tetri, B. / Loomba, R. / Harrison, S. / Abdelmalek, M. / Lawitz, E. / Halegoua-DeMarzio, D. / Dong, Y. / Noviello, S. et al. | 2017
- S90
-
MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infectionReau, N. / Kwo, P.Y. / Rhee, S. / Brown, R.S. / Agarwal, K. / Angus, P. / Gane, E. / Kao, J.-H. / Mantry, P.S. / Reddy, K.R. et al. | 2017
- S91
-
Controlled attenuation parameter as an additional tool for the non-invasive prediction of first clinical decompensation in compensated advanced chronic liver diseaseMargini, C. / Murgia, G. / Stirnimann, G. / De Gottardi, A. / Semmo, N. / Casu, S. / Bosch, J. / Dufour, J.-F. / Berzigotti, A. et al. | 2017
- S92
-
NGM282, a novel variant of FGF19, significantly reduces hepatic steatosis and key biomarkers of NASH: results of a Phase 2, multicenter, randomized, double-blinded, placebo controlled trial in biopsy-confirmed NASH patientsHarrison, S.A. / Abdelmalek, M.F. / Trotter, J.F. / Paredes, A.H. / Arnold, H.L. / Kugelmas, M. / Bashir, M.R. / Ling, L. / Rossi, S.J. / DePaoli, A.M. et al. | 2017
- S95
-
Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in EuropeMarshall, A.D. / Nielsen, S. / Cunningham, E.B. / Aghemo, A. / Alho, H. / Backmund, M. / Bruggmann, P. / Dalgard, O. / Flisiak, R. / Foster, G. et al. | 2017
- S96
-
One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial: REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infectionBazinet, M. / Pantea, V. / Cebotarescu, V. / Cojuhari, L. / Jimbei, P. / Krawczyk, A. / Vaillant, A. et al. | 2017
- S97
-
Preventing decompensation of cirrhosis with clinically significant portal hypertension and without high-risk varices: a new indication for non-selective beta-blockers (NSBB)Villanueva, C. / Albillos, A. / Genescà, J. / Garcia-Pagan, J.C. / Calleja, J.L. / Aracil, C. / Bañares, R. / Morillas, R. / Poca, M. / Peñas, B. et al. | 2017
- S98
-
A Notch receptor-selective Jagged1 mutation causes an Alagille syndrome phenotype in miceAndersson, E.R. et al. | 2017
- S99
-
Establishing the foundation for a novel, first-in-class, fatty acid synthase inhibitor, TVB-2640, for the treatment of NASHDuke, G. / Wagman, A.S. / Buckley, D. / McCulloch, W. / Kemble, G. et al. | 2017
- S101
-
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 studyKoh, C. / Surana, P. / Han, T. / Fryzek, N. / Kapuria, D. / Etzion, O. / Takyar, V. / Rotman, Y. / Canales, R. / Dahari, H. et al. | 2017
- S102
-
Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 StudyRockstroh, J. / Lacombe, K. / Viani, R.M. / Orkin, C. / Wyles, D. / Luetkemeyer, A. / Soto-Malave, R. / Flisiak, R. / Bhagani, S. / Sherman, K.E. et al. | 2017
- S103
-
A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysisTurco, L. / Villanueva, C. / La Mura, V. / Garcia-Pagan, J.C. / Reiberger, T. / Genesca, J. / Groszmann, R.J. / Sharma, B.C. / Merkel, C. / Bureau, C. et al. | 2017
- S104
-
Severe periodontitis predicts higher cirrhosis mortalityGrønkjær, L.L. / Holmstrup, P. / Schou, S. / Jepsen, P. / Vilstrup, H. et al. | 2017
- S106
-
Incidence and prevalence of recorded non-alcoholic fatty liver disease in four large European primary care databases covering 21.9 million adultsAlexander, M. / Loomis, K. / Fairburn-Beech, J. / van der Lei, J. / Duarte-Salles, T. / Ansell, D. / Pasqua, A. / Rijnbeek, P. / Avillach, P. / Kendrick, S. et al. | 2017
- S107
-
Worldwide lack of early referral of patients with alcoholic liver disease: results of the global alcoholic liver disease survey (GLADIS)Shah, N.D. / Cots, M.V. / Zhang, C. / Zahiragic, N. / Yu, Y. / Yacoub, M. / Wu, P. / Wandera, A. / Vorobioff, J. / Traquino, E.S.D.S. et al. | 2017
- S108
-
The roles of glycogen synthase kinase-3 genes in liver functionsPatel, P. / Patel, S. / Woodgett, J.R. et al. | 2017
- S109
-
Prospective prevalence study of adult NAFLD/NASH utilizing multi-modality imaging compared with liver bopsyHarrison, S.A. / Roberts, K.K. / Paredes, A.H. / Lisanti, C. / Schwope, R. / Cebe, K.M. / Whitehead, J.M.A. / Paradis, V. / Bedossa, P. / Aden, J.K. et al. | 2017
- S110
-
Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosisFrancque, S. / Cordonnier, G. / Texier, F. / Ratziu, V. / Harrison, S. / Bedossa, P. / Anstee, Q. / Roudot, A. / Megnien, S. / Hum, D. et al. | 2017
- S112
-
Propranolol versus endoscopic variceal ligation in patients with cirrhosis and ascites- a randomised controlled trialSingh, V. / Kumar, P. / Vijayvergia, R. / Bhalla, A. et al. | 2017
- S113
-
iPLA2beta protects aged male mice from liver fibrosis and intestinal atrophy by modulating phospholipid and enterohepatic bile acid metabolismJiao, L. / Gan-Schreier, H. / Zhu, X. / Wei, W. / Tuma-Kellner, S. / Liebisch, G. / Stremmel, W. / Chamulitrat, W. et al. | 2017
- S114
-
Ki67, cyclin D and caspase 3 allow distinction of two sub-groups of alcoholic patients at early stages of alcoholic liver diseaseStärkel, P. / Desaeger, C. / Lanthier, N. / Leclercq, I. et al. | 2017
- S116
-
Drinking behaviour and rs738409:G in PNPLA3 are associated with slower recovery of liver function following severe alcoholic hepatitisAtkinson, S.R. / Way, M.J. / McQuillin, A. / Morgan, M.Y. / Thursz, M.R. et al. | 2017
- S117
-
Hepatocyte but not macrophage-specific stard1 deletion attenuates alcoholic liver diseaseRibas, V. / Nuñez, S. / Garcia-Ruiz, C. / Fernandez-Checa, J. et al. | 2017
- S118
-
Risk factors of early emergent hospital readmission and 6-month mortality in patients with cirrhosis after a recovery from bacterial or fungal infectionMorando, F. / Piano, S. / Rosi, S. / Stanco, M. / Pilutti, C. / Vettore, E. / Romano, A. / Fasolato, S. / Tonon, M. / Brocca, A. et al. | 2017
- S119
-
Von Willebrand Factor as a predictor of short-term morbidity and mortality in comparison with conventional scoring systemsKulkarni, A.V. / Venkatkrishnan, L. / Krishnaveni, J. / Swaminathan, M. / Vegiraju, V. / Murthy, K. / Dharamsi, S. / Krishna, P. et al. | 2017
- S120
-
Rapid change of liver stiffness after variceal ligation and TIPS implantationPiecha, F. / Paech, D. / Sollors, J. / Seitz, H.-K. / Rössle, M. / Mueller, S. et al. | 2017
- S121
-
Outcome of liver transplant recipients after the first episode of bacterial infectionFerrarese, A. / Zanetto, A. / Germani, G. / Gambato, M. / Russo, F.P. / Cillo, U. / Angeli, P. / Burra, P. / Senzolo, M. et al. | 2017
- S122
-
Usefulness of the six-minute walk as a predictor of mortality in patients with decompensated cirrhosisGuillen, E.M. / Martinez, S.G.M. / Ávila, J.F.S. / Juarez, I.G. et al. | 2017
- S123
-
High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosisAgiasotelli, D. / Alexopoulou, A. / Vasilieva, L. / Mani, I. / Hadziyannis, E. / Goukos, D. / Daikos, G.L. / Dourakis, S.P. et al. | 2017
- S124
-
Uncontrolled glycaemia increases the risk of developing spontaneous bacterial peritonitis in patients with cirrhosisServin-Caamaño, A.I. / Navarro-Estrada, A.E. / Pérez-Hernández, J.L. / de Guevara, V.L.-L. / Cruz-Estrada, A. / de La Tijera, F.H. et al. | 2017
- S125
-
Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosisKutsenko, A. / Le, A. / Trinh, S. / Dang, H. / Nguyen, M. et al. | 2017
- S126
-
C reactive protein contributes to the early prediction of 90-day mortality risk in acutely decompensated cirrhotic patientsClemente, A. / Romero, M. / Martínez, C. / Bueno, A. / Antona, M. / Salcedo, M. / Fernández, A. / Catalina, M.V. / Clemente, G. / Rincón, D. et al. | 2017
- S128
-
Prevalence of portal trombosis related to the degree of portal hypertensionPuente, A. / Fortea, J.I. / Ruiz, P. / Loste, M.T.A. / Cabezas, J. / Llerena, S. / Estebanez, A. / Fábrega, E. / Crespo, J. et al. | 2017
- S129
-
Long-term prognosis following acute-on-chronic liver failureYoon, E.L. / Kim, T.Y. / Song, D.S. / Kim, H.Y. / Kim, C.W. / Jung, Y.K. / Sinn, D.H. / Jang, J.Y. / Kim, M.Y. / Jeong, S.W. et al. | 2017
- S131
-
Resistant bacterial infections in cirrhosis: a French observational prospective multicentre nationwide study (RESIST study)Pauwels, A. / Meunier, L. / Boivineau, G. / Martin, T. / Touze, I. / Zuberbuhler, F. / Allaire, M. / Margos, W. / Carbonell, N. / Lambare, B. et al. | 2017
- S133
-
Bioelectrical impedance vector analysis is an objective method for nutritional assessment in patients with cirrhosisRuiz-Margáin, A. / Rodriguez, R.U.M. / Cuevas, A.E. / Cubero, F.J. / Trautwein, C. / Torre, A. et al. | 2017
- S134
-
Human ascites microfibril-associated protein 4 is an independent predictor of mortality in decompensated cirrhosisMadsen, B.S. / Kjærgaard, M. / Thiele, M. / Pohlmann, A. / Lutz, P. / Schierwagen, R. / Klein, S. / Jansen, C. / Lehmann, J. / Mortensen, C.O. et al. | 2017
- S136
-
Ethnic differences in overall survival of patients with cirrhosis: results of a cohort of 2939 United States patients with long-term follow-upZhao, C. / Nguyen, P. / Hoang, J.K. / Trinh, S. / Cho, C. / Yasukawa, L.A. / Weber, S. / Nguyen, M. et al. | 2017
- S137
-
Urinary MicroARNs as potential biomarkers to predict the evolution of kidney function after liver transplantation in patients with cirrhosisLejealle, C. / Roux, O. / Weiss, E. / Fasseu, M. / Moreau, R. / Durand, F. / Francoz, C. et al. | 2017
- S138
-
The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysisChang, C.-Y. / Su, C.-W. / Hsieh, W.-Y. / Chau, G.-Y. / Hou, M.-C. / Chen, P.-H. / Lee, P.-C. / Huo, T.-I. / Huang, Y.-H. / Lin, H.-C. et al. | 2017
- S139
-
Not all of the patients with hepatitis B-related hepatocellular carcinoma require endoscopic screening for esophageal varices: a large cohort studyChang, C.-Y. / Su, C.-W. / Chen, P.-H. / Hou, M.-C. / Lee, P.-C. / Lin, H.-C. / Huang, Y.-H. / Huo, T.-I. / Wu, J.-C. et al. | 2017
- S140
-
Bone marrow of cirrhotic patients displays features of myeloid biasnessBihari, C. / Lal, D. / Sharma, S. / Sukriti, S. / Bhadoria, A.S. / Rastogi, A. / Sarin, S.K. et al. | 2017
- S141
-
Polyunsaturated fatty acids and eicosanoids in ascites serve as potential new biomarkers for complications in liver cirrhosisEngelmann, C. / Degenhardt, V. / Dorow, J. / Krohn, S. / Herber, A. / Mueller, N. / Herta, T. / Thiery, J. / Ceglarek, U. / Berg, T. et al. | 2017
- S143
-
Low sensitivity to thrombomodulin in patients with cirrhosis; Impact of factor VIII increase and protein C deficiencyDuron, C. / Lebreton, A. / Sinegre, T. / Massoulier, S. / Muti, L. / Lamblin, G. / Pereira, B. / Berger, M. / Abergel, A. et al. | 2017
- S144
-
Impaired cerebral oxygenation, but preserved cerebrovascular reactivity, in an animal model of hepatic encephalopathyHadjihambi, A. / Hosford, P. / Davies, N. / Jalan, R. / Gourine, A. et al. | 2017
- S145
-
Extracellular vesicles induce renal tubular cells apoptosis, oxidative stress and functional abnormalities in patients with an acute decompensation of cirrhosisBrocca, A. / Medica, D. / Piano, S. / Romano, A. / Tonon, M. / Sticca, A. / Vincenzo, C. / Angeli, P. et al. | 2017
- S147
-
Osteoprotegerin is more than a serum marker in liver fibrosisAdhyatmika, A. / Beljaars, L. / Putri, K.S.S. / Reker-Smit, C. / Boorsma, C.E. / Guney, B. / Haak, A. / Post, E. / Poelstra, K. / Melgert, B.N. et al. | 2017
- S149
-
Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patientsSingh, A. / Lopez, R. / Le, P. / Alkhouri, N. et al. | 2017
- S150
-
Validation of non-invasive fibrosis assessments in biopsy-proven non-alcoholic fatty liver diseaseDrolz, A. / Wehmeyer, M. / Diedrich, T. / zur Wiesch, J.S. / Lohse, A.W. / Kluwe, J. et al. | 2017
- S151
-
Pharmacokinetics of selonsertib, GS-9674, and/or GS-0976 in combination in healthy subjectsNelson, C.H. / Kirby, B.J. / Lu, N. / McColgan, B. / Djedjos, C.S. / Myers, R.P. / Cuvin, J. / Qin, A. / Mathias, A. et al. | 2017
- S152
-
Combination of long term N-Acetylcysteine and Ursodeoxycolic Acid in NASH: a multicenter randomized control trialOliveira, C.P. / Cotrim, H.P. / Cristina, A. / Siqueira, G. / Salgado, A.L.A. / Stefano, J.T. / Brizolla, P. / Mattos, L. / Martins, A.H.B. / Andrade, A.R. et al. | 2017
- S153
-
Autonomic function is impaired across the spectrum of NAFLDHoughton, D. / Zalewski, P. / Cassidy, S. / Thoma, C. / Hallsworth, K. / Avery, L. / Lukowska, A.B. / Hardy, T. / Burt, A.D. / Masson, S. et al. | 2017
- S155
-
Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLDGómez, E.V. / Aller, R. / Gallego-Durán, R. / Bañales, J. / Loste, M.T.A. / García-Monzón, C. / Ramirez, H.P. / García-Torres, M.L. / Gómez-Camarero, J. / Caballería, J. et al. | 2017
- S156
-
Automated, fully quantitative analysis by using second harmonic generation microscopy in the fibrosis progression of nonalcoholic fatty liver diseaseLiu, F. / Zhao, J.-M. / Liu, P.-H. / Rao, H.-Y. / Zhang, W. / Wu, N. / Wei, L. et al. | 2017
- S158
-
Presence of metabolic syndrome and low CD4 count are independently associated with liver fibrosis in human immunodeficiency virus-infected patients with non-alcoholic fatty liverPerazzo, H. / Cardoso, S.W. / Yanavich, C. / Munteanu, M. / Morata, M. / Simplicio, P. / Cardoso, C. / Almeida, C. / Poynard, T. / Veloso, V.G. et al. | 2017
- S159
-
Impact of modest weight reduction on liver histology, portal pressure, and clinical events in patients with compensated cirrhosis due to nonalcoholic steatohepatitisBosch, J. / Harrison, S. / Ratziu, V. / Shiffman, M. / Diehl, A. / Caldwell, S. / Rockey, D. / Ghalib, R. / Thuluvath, P. / Abdelmalek, M. et al. | 2017
- S160
-
A pragmatic algorithm to rule out Non-alcoholic steatohepatitis in patients at risk of non-alcoholic fatty liver disease in spite of a normal ultrasoundAmpuero, J. / Aller, R. / Gallego-Durán, R. / Bañales, J. / Loste, A. / Teresa, M. / García-Monzón, C. / Vilar-Gómez, E. / Escudero, A. / Gómez-Camarero, J. et al. | 2017
- S161
-
The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver diseaseBoursier, J. / Vergniol, J. / Lannes, A. / Hiriart, J.-B. / Oberti, F. / Le Bail, B. / Michalak, S. / Chermak, F. / Bertrais, S. / Foucher, J. et al. | 2017
- S162
-
Anti-fibrotic effect of NV556, a sanglifehrin-based cyclophilin inhibitor, in a preclinical model of non-alcoholic steatohepatitisGrönberg, A. / Elmér, E. / Gregory, M. / Moss, S. / Hansson, M. et al. | 2017
- S163
-
The immunomodulatory activity of the protease-inhibitor SerpinB3 in vivo and in vitroCappon, A. / Quarta, S. / Biasiolo, A. / Turato, C. / Villano, G. / Ruvoletto, M. / Sutti, S. / Bruzzi, S. / Novo, E. / Morello, E. et al. | 2017
- S164
-
CD40 activation alleviates steatosis in cultured hepatocytesChatzigeorgiou, A. / Baer, K. / Chavakis, T. et al. | 2017
- S166
-
The gut microbiome of lean patients with non-alcoholic steatohepatitis: comparison with overweight/obese counterparts and healthy subjects, correlation with dietary intake and liver histologyDuarte, S.M. / Stefano, J.T. / Miele, L. / Ponziani, F.R. / Souza, M. / Rodrigues, L. / Costa, F.G. / Toda, K. / Mazo, D.F. / Sabino, E.C. et al. | 2017
- S167
-
High fat diet related liver damage anticipates the appearance of cardiac injury: the role of Klf15 and tafazzinPorcu, C. / Barbaro, B. / Antonucci, L. / Viscomi, C. / Balsano, C. et al. | 2017
- S169
-
Hypoxia-inducible factor 2alpha drives the progression of experimental non-alcoholic fatty liver disease by stimulating hepatocyte production of histidine rich glycoproteinMorello, E. / Sutti, S. / Foglia, B. / Cannito, S. / Novo, E. / Bocca, C. / Bruzzì, S. / Bugianesi, E. / Albano, E. / Parola, M. et al. | 2017
- S171
-
Genotypic-phenotypic profile of Wilson disease patients in Lebanon: comparison with regional Arab countriesEl Haddad, A.K. / Usta, J. / Jomaa, M. / Katerji, M. / Barada, K. et al. | 2017
- S172
-
Age-dependent glycosylation of the sodium taurocholate co-transporte polypeptide: from neonates to adult human primary hepatocytesSargiacomo, C. / Najimi, M. / Sokal, E. et al. | 2017
- S176
-
Multi-center study of liver disease in alpha1-antitrypsin deficiency: non-invasive evaluation of liver fibrosis in homozygous PiZZ patientsHamesch, K. / Scholten, D. / Spivak, I. / Voss, J. / Bretag, T. / Wetzel, M. / Siegmund, B. / Reichert, M. / Bals, R. / Lammert, F. et al. | 2017
- S177
-
GANAB mutations: a possible lead to a common hepatic cystogenesis pathway in autosomal dominant polycystic kidney and liver disease?Van De Laarschot, L.F.M. / te Morsche, R.H. / Drenth, J.P.H. et al. | 2017
- S178
-
New molecular classification of hepatoblastoma through an integrative genomic and transcriptomic studySimon-Coma, M. / Akers, N. / Sia, D. / Royo, L. / Carrillo, J. / Pedersen, K. / Mallo, M. / Arnal, M. / Kuchuk, O. / Gambato, M. et al. | 2017
- S179
-
Variants in TM6SF2 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosisBuch, S. / Way, M.J. / Stickel, F. / Ryan, E. / Zoller, H. / Griffiths, W.J.H. / McQuillin, A. / Zwerina, J. / Ryan, J.D. / Gallati, S. et al. | 2017
- S180
-
Antibiotics induce remission in pediatric PSC-AIH overlap syndrome allowing corticosteroid-free therapySambon, P. / Varma, S. / Komuta, M. / Clapuyt, P. / Sokal, E. et al. | 2017
- S181
-
GMP-level isolation, quality assessment and biosafety distribution evaluation on human amnion epithelial cell for cell-based therapiesGramignoli, R. / Srinivasan, R.C. / Kristina, K. / Askelof, U. / Zabulica, M. / Strom, S.C. et al. | 2017
- S182
-
Fontan-associated liver disease: diagnosis by elastography and laparoscopic liver biopsyKoizumi, Y. / Hirooka, M. / Yukimoto, A. / Imai, Y. / Nakamura, Y. / Watanabe, T. / Yoshida, O. / Tokumoto, Y. / Higaki, T. / Abe, M. et al. | 2017
- S183
-
Early treatment of HCV-recurrent infection post liver transplantation in the era of the new direct acting antivirals, what we learned till now?Sakr, M.A. / Dabbous, H.M. / Montasser, I.F. / Ebada, H.E. / Abdelhafeez, K.A. / Massoud, Y.M. / Bahaa, M.M. / Elmeteini, M.S. et al. | 2017
- S184
-
No increase in graft fibrosis for hepatitis B surface antigen positive patients after liver transplantation using entecavir monotherapyFung, J.Y.Y. / Wong, T. / Chok, K. / Chan, A. / Sin, S.-L. / Ng, K. / Cheung, T.-T. / Dai, J. / Seto, W.-K. / Lai, C.-L. et al. | 2017
- S185
-
Progression of familial amyloidosis after domino liver transplantation in donor and recipientVollmar, J. / Schmid, J.C. / Hoppe-Lotichius, M. / Emrich, T. / Geber, C. / Schad, A. / Mittler, J. / Lang, H. / Galle, P.R. / Zimmermann, T. et al. | 2017
- S186
-
Donor mannose-binding lectingene polymorphisms increase the risk of severe bacterial infections after liver transplantationLombardo, J. / Sanclemente, G. / Colmenero, J. / Español, M. / Arias, M.T. / Ruiz, P. / Mauro, E. / Sastre, L. / Crespo, G. / Moreno, A. et al. | 2017
- S187
-
Occult hepatitis B virus persistence in liver transplant recipients despite prophylactic hepatitis B immune globulin and potent nucleos/tide analogues therapyLau, K.C. / Osiowy, C. / Giles, E. / van Marle, G. / Burak, K.W. / Coffin, C.S. et al. | 2017
- S189
-
The golden hour: length of total warm ischemia time presages development of severe acute kidney injury after DCD liver transplantationKalisvaart, M. / Umbro, I. / de Haan, J. / Scalera, I. / Schlegel, A. / IJzermans, J. / Perera, T. / Isaac, J. / Mitterhofer, A.P. / Muiesan, P. et al. | 2017
- S190
-
Entecavir or tenofovir monotherapy prevents hepatitis B virus recurrence in liver transplant recipients: a 5-year follow-up study after hepatitis B immunoglobulin withdrawalManini, M.A. / Bruce, M. / Whitehouse, G. / Carey, I. / Wang, B. / Gonsalkorala, E. / Considine, A. / Heneghan, M. / Lampertico, P. / Agarwal, K. et al. | 2017
- S191
-
Differences in the occurrence of metabolic syndrome between patients treated with a calcineurin inhibitor and patients treated with an mTOR inhibitor after liver transplantationTer Avest, M.M. / Guichelaar, M.M. / Brusse-Keizer, M.G. / Heinzow, H.S. / Schmidt, H.H. et al. | 2017
- S192
-
The association of the metabolic syndrome with cardiovascular and cerebrovascular outcomes and renal dysfunction after liver transplantationHo, O.F. / Lipka, G.M. / David, M.C. / Macdonald, G.A. et al. | 2017
- S194
-
History of marijuana use does not affect outcomes on the liver transplant waitlistKotwani, P. / Saxena, V. / Dodge, J. / Roberts, J. / Yao, F. / Hameed, B. et al. | 2017
- S196
-
MELD score >19 on day five after liver transplant in hepatitis C virus-positive recipients: impact on 90-day graft loss and analysis of predictorsMartini, S. / Tandoi, F. / di Bergamo, L.T. / Strona, S. / Sacco, M. / Maione, F. / Gonella, F. / Salizzoni, M. / Saracco, G.M. / Romagnoli, R. et al. | 2017
- S197
-
Evolution of body weight parameters up to 3 years after liver transplantation: the prospective Swiss transplant cohort studyBeckmann, S. / Dutkowski, P. / Nikolic, N. / Denhaerynck, K. / Binet, I. / Koller, M. / Boely, E. / De Geest, S. et al. | 2017
- S198
-
The risk of death after liver transplantation due to increasing donor age is highest in young recipientsBittermann, T. / Goldberg, D.S. et al. | 2017
- S200
-
A glycomic serum marker analysed at one week after liver transplantation is an independent predictor of graft loss during the first year after liver transplantationVerhelst, X. / Geerts, A. / Rogiers, X. / Vanlander, A. / Berrevoet, F. / Callewaert, N. / Troisi, R.I. / Van Vlierberghe, H. et al. | 2017
- S201
-
Inhibition of NADPH oxidase-2 and P38 mitogen activated protein kinase suppresses acrolein aggravated hepatic ischemia reperfusion injury through neutrophil extracellular trapsSuyavaran, A. / Thirunavukkarasu, C. et al. | 2017
- S202
-
Herpesviruses in bile: increasing sensitivity by testing the right compartmentRauber, C. / Bartelheimer, K. / Gotthardt, D. et al. | 2017
- S203
-
Approaches to fabricate practical recellularized liver graft using primary liver cells-our seeding method for optimal distribution of parenchymal and endothelial cellsKojima, H. / Yasuchika, K. / Fukumitsu, K. / Ishii, T. / Ogiso, S. / Miyauchi, Y. / Yamaoka, R. / Kawai, T. / Katayama, H. / Yoshitoshi, E. et al. | 2017
- S204
-
Correlation of efficacy and safety outcomes with regorafenib exposure in patients with hepatocellular carcinomaCleton, A. / Graudenz, K. / Huang, F. / Fiala-Buskies, S. / Ploeger, B. / Schlief, S. / Bonata, P. / Meinhardt, G. et al. | 2017
- S205
-
The systemic inflammatory response is a prognostic marker in human immunodeficiency virus-infected patients with hepatocellular carcinomaPinato, D.J. / Merli, M. / Pria, A.D. / Jamshaid, S. / Parker, K. / Pagani, N. / Hasson, H. / Uberti-Foppa, C. / Messina, E. / Sharma, R. et al. | 2017
- S207
-
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaArbelaiz, A. / Azkargorta, M. / Santos-Laso, Á. / Perugorria, M.J. / Erice, O. / Gonzalez, E. / Lapitz, A. / Izquierdo, L. / Olaizola, P. / Lee, P.Y. et al. | 2017
- S208
-
CEUS LI-RADS are effective in predicting the risk hepatocellular carcinoma of liver nodulesTerzi, E. / De Bonis, L. / Leoni, S. / Benevento, F. / Granito, A. / Tovoli, F. / Pini, P. / Bolondi, L. / Piscaglia, F. et al. | 2017
- S209
-
Serum Markers for early diagnosis of hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virological response to direct-acting antivirals treatmentSangiovanni, A. / D’Ambrosio, R. / Lunghi, G. / Bruccoleri, M. / Alimenti, E. / Borghi, M. / Perbellini, R. / Aghemo, A. / Iavarone, M. / Colombo, M. et al. | 2017
- S210
-
Interferon-free therapy of chronic hepatitis C does not change the short-term risk for de novo hepatocellular carcinomas in patients with liver cirrhosisMettke, F. / Schlevogt, B. / Deterding, K. / Wranke, A. / Port, K. / Manns, M.P. / Vogel, A. / Cornberg, M. / Wedemeyer, H. et al. | 2017
- S212
-
Predictors for successful downstaging in patients with BCLC intermediate stage hepatocellular carcinomaBroekhoven, A. / Takkenberg, B. / Sprengers, D. / Ramsoekh, S. / van Erpecum, K. / van Meer, S. / Verspaget, H. / Burgmans, M. / Osanto, S. / Baranski, A. et al. | 2017
- S213
-
Portal vein infiltration in patients with hepatocellular carcinoma: the impact of correct classificationKloeckner, R. / Steinle, V. / Koch, S. / Dos Santos, D.P. / Marquardt, J. / Sprinzl, M. / Lang, H. / Dueber, C. / Galle, P. / Woerns, M. et al. | 2017
- S214
-
The effect of antiviral treatment on hepatitis B virus reactivation after radiotherapy for hepatocellular carcinomaJun, B.G. / Kim, Y.D. / Cheon, G.J. / Kim, S.G. / Kim, Y.S. / Jeong, S.W. / Jang, J.Y. / Lee, S.H. / Kim, H.S. et al. | 2017
- S215
-
Operability of perihilar cholangiocellular carcinoma can be reliably predicted by combination of endoscopic retrograde cholangiography, endoscopic ultrasound and computer tomography as variables in the European staging systemSchlevogt, B. / Kammerer, S. / Lessing, M. / Domagk, D. / Hüsing-Kabar, A. / Kabar, I. / Schmidt, H.H.-J. / Wolters, H. / Meister, T. / Heinzow, H.S. et al. | 2017
- S217
-
Clinical features of hepatocellular carcinoma in the elderly in a hepatitis B endemic country – a comparative study of 1430 casesCheah, C.-C.M. / Goh, B.-B.G. / Chang, P.-E. / Tan, C.-K. et al. | 2017
- S218
-
Hepatocellular carcinoma and rheumatoid arthritis: a 10-year population-based propensity-score matched cohort study in TaiwanHsu, C.-S. / Lang, H.-C. / Huang, K.-Y. / Chen, C.-L. et al. | 2017
- S219
-
The malignant transformation of hepatocellular adenoma: experience of a French liver centerSempoux, C. / Blanc, J.F. / Le Bail, B. / Chiche, L. / Balabaud, C. / Bioulac-Sage, P. et al. | 2017
- S220
-
Hepatocellular carcinoma diagnostic performance of liver imaging reporting and data system for contrast enhanced ultrasound and of quantitative contrast enhanced ultrasoundCristea, C.G. / Sandulescu, L.D. / Saftoiu, A. / Cazacu, S.M. / Gheonea, I.A. / Ciurea, T. et al. | 2017
- S222
-
Phase 3 biomarker study for HCC surveillance using AFP, AFP L-3 and DCP. A prospective collection with retrospective blinded evaluationEl-Serag, H. / White, D. / Tayob, N. / Alsarraj, A. / Mori, Y. / Yamada, H. / Kanwal, F. et al. | 2017
- S223
-
Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational studyYen, C. / Sharma, R. / Rimassa, L. / Arizumi, T. / Bettinger, D. / Evans, J. / Pressiani, T. / Burlone, M.E. / Pirisi, M. / Giordano, L. et al. | 2017
- S225
-
Role of RAS-dependent signaling pathways in hepatic carcinogenesisLechler, C. / Roesner, T. / Kohnke-Ertel, B. / Saur, D. / Sage, J. / Schmid, R.M. / Ehmer, U. et al. | 2017
- S226
-
Inhibition of lymph node metastasis by CTGF in Notch1 driven malignant transformation of rat liver oval cellsShi, X.-D. / He, S.-P. / Wu, W.-R. / Fu, H.-W. / Zhang, R. / Xu, L.-B. / Yu, X.-H. / Zeng, H. / Liu, C. et al. | 2017
- S227
-
Functional role of CCL5/RANTES for hepatocellular carcinoma progression during chronic liver diseaseMohs, A. / Kuttkat, N. / Reißing, J. / Zimmermann, H.W. / Sonntag, R. / Youssef, S.A. / de Bruin, A. / Cubero, F.J. / Trautwein, C. et al. | 2017
- S228
-
Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient managementAbouhammoud, A. / Henriet, E. / Dupuy, J.-W. / Dartigues, B. / Ezzoukhry, Z. / Senant, N. / Blanc, J.-F. / Lebail, B. / Nikolski, M. / Bioulac-Sage, P. et al. | 2017
- S229
-
Cerium oxide nanoparticles display anti-tumoral activity and improve survival in experimental hepatocellular carcinomaFernandez-Varo, G. / Oró, D. / Yudina, T. / Carvajal, S. / Marfà, S. / Boix, L. / Perramón, M. / Oller, L. / Casals, G. / Morales-Ruiz, M. et al. | 2017
- S230
-
A new in vitro hepatocellular carcinoma model based on human normal and fibrotic 3D extracellular matrix scaffold bio-engineeringTelese, A. / Mazza, G. / Longato, L. / Al-Akkad, W. / Frenguelli, L. / Marrone, G. / Tamburrino, D. / Spoletini, G. / Hall, A. / Luong, T.V. et al. | 2017
- S231
-
microRNA-34a and natural killer cells: an immuno-epigenetic approach to halt hepatocellular carcinoma progressionAbdelhamid, A.K. / Yacoub, R.A. / Fawzy, I.O. / Gomaa, A. / Hosny, K. / Hamza, M.T. / Esmat, G. / Waked, I. / Abdelaziz, A.I. et al. | 2017
- S231
-
Chronic treatment with over-the-counter H1 or H2 histamine receptor blockers decreases cholangiocarcinoma xenograft tumor growth, angiogenesis and EMTHargrove, L. / Kennedy, L. / Demieville, J. / Francis, H. et al. | 2017
- S232
-
The impact of bariatric surgery on nonalcoholic fatty liver disease and cardiovascular risk utilizing non-invasive measuresNetanel, C. / Goitein, D. / Rubin, M. / Shechter, M. / Kleinbaum, Y. / Katsherginsky, S. / Hermon, H. / Hemi, R. / Tsaraf, K. / Donuzi, A. et al. | 2017
- S233
-
Noninvasive diagnosis of hepatic fibrosis by biofibroscore® in patients with chronic hepatitis C virus infectionLiu, C.-H. / Liu, C.-J. / Su, T.-H. / Yang, H.-C. / Kao, J.-H. / Chen, D.-S. / Chen, P.-J. et al. | 2017
- S234
-
Variability of intrahepatic fat distribution and optimal measurement of hepatic fat amount using MRI proton density fat fractionJun, D.W. / Ahn, S.B. / Saeed, W.K. / Oh, H.W. / Jeong, J.Y. / Sohn, J.H. / Jang, E.C. / Kang, B.-K. et al. | 2017
- S235
-
The role of serial ARFI elastography in confirming remission in active autoimmune liver disease: a controlled study with long follow upSherman, D.I. / Gandy, N. / Lung, P. / Tadrous, P. / Bassett, P. / Shorvon, P. et al. | 2017
- S236
-
Urinary metabotypes in patients with chronic hepatitis C virus infection as revealed by nuclear magnetic resonance-based metabolomicsBiliotti, E. / Tomassini, A. / Palazzo, D. / Capuani, G. / Sciubba, F. / Esvan, R. / De Angelis, M. / Franchi, C. / Iaiani, G. / Maida, P. et al. | 2017
- S238
-
Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimensRavaioli, F. / Marasco, G. / Reggiani, M.L.B. / Mazzella, G. / Buonfiglioli, F. / Porro, A. / Brillanti, S. / Colecchia, A. / Festi, D. et al. | 2017
- S239
-
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patientsRavaioli, F. / Mazzella, G. / Andreone, P. / Conti, F. / Brillanti, S. / Buonfiglioli, F. / Serio, I. / Verucchi, G. / Reggiani, M.L.B. / Marasco, G. et al. | 2017
- S240
-
Non-invasive assessment of liver fibrosis by point share wave elastography in primary biliary cholangitis: comparison with fibroscan® and fibrosis scoresSaffioti, F. / Rosselli, M. / Roccarina, D. / Pinzani, M. / Marshall, A. / Thorburn, D. et al. | 2017
- S241
-
Assessment of fibrosis markers in a large cohort of chronic hepatitis B patients in EthiopiaDesalegn, H. / Aberra, H. / Berhe, N. / Gundersen, S.G. / Johannessen, A. et al. | 2017
- S242
-
Characterisation of liver fat in the UK biobank cohortWilman, H.R. / Kelly, M. / Jandor, A. / Bell, J. / Banerjee, R. / Thomas, L. et al. | 2017
- S243
-
Novel mapping of fibrosis and hepatic inflammation in NASH patients with dual R2 MRI relaxometryFilho, H.M.L. / Chua-anusorn, W. / Oliveira, C.P. / Carrilho, F.J. / Lima, F. / Alves, V. / Clark, P. / Rocha, M. et al. | 2017
- S244
-
Hepatic iron overload analysis bymagnetic resonance imaging in a non-alcoholic fatty liver disease populationFilho, H.M.L. / Fabrega, P. / Chua-anusorn, W. / Oliveira, C.P. / Carrilho, F.J. / Lima, F. / Cercato, C. / Clark, P. / Rocha, M. et al. | 2017
- S246
-
Common polymorphisms in the TLR3 gene are stronger associated with spontaneous clearance of Hepatitis B virus infection in caucasians than variants of the HLA geneFischer, J. / Koukoulioti, E. / Schott, E. / Fueloup, B. / Heyne, R. / Berg, T. / van Bömmel, F. et al. | 2017
- S247
-
Serum hepatitis B core antibody as a novel tool to assess hepatic inflammation guide antiviral decision-making in chronic hepatitis B patients with normal alanine aminotransferase levelsZhou, J. / Zhao, H. / Yan, L. / Wang, G. et al. | 2017
- S248
-
Summary of the FDA report: twenty four hepatitis B reactivation cases during hepatitis C direct acting antiviral therapyBhamidimarri, K.R. / Widjaja, D. / Satapathy, S. / O’Brien, C. / Martin, P. et al. | 2017
- S249
-
A nationwide seroprevalence of hepatitis a in Republic of Korea from 2005 to 2014, before and after peak outbreak in 2009Jeong, S.-H. / Kim, K.-A. / Lee, A. / Ki, M. / Yoon, C.J. et al. | 2017
- S250
-
Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNAColagrossi, L. / Salpini, R. / Scutari, R. / Battisti, A. / Piermatteo, L. / Bertoli, A. / Menichini, C. / Trimoulet, P. / Fleury, H. / Nebuloso, E. et al. | 2017
- S251
-
Absence of hepatitis B reactivation among veterans with serological evidence of previous hepatitis B infection receiving anti-hepatitis C direct acting antiviralsTang, L. / Tolaymat, M. / Stonesifer, E. / Kottilil, S. / Wilson, E. et al. | 2017
- S252
-
Prevalence, determinants of chronic hepatitis B infection and hepatitis B genotypes in multi-ethnic SurinameMac Donald-Ottevanger, M.S. / van de Laar, T. / Zijlmans, W. / Prins, M. / Brinkman, K. / Roosblad, J. / Codrington, J. / van der Helm, J. / Vreden, S. et al. | 2017
- S253
-
Serum hepatitis B virus RNA level is associated with hepatitis B virus genotype and BCP mutations in untreated patients with HBeAg positive chronic hepatitis Bvan Campenhout, M.J. / van Bömmel, F. / Grossmann, M. / Fischer, J. / Deichsel, D. / Boonstra, A. / van Vuuren, A.J. / Berg, T. / Hansen, B.E. / Janssen, H.L. et al. | 2017
- S254
-
Clinical and virological outcomes of hepatitis B virus inactive carriers and gray zone patients: a comparative analysis using current EASL and AASLD Guidelines criteriaBonacci, M.S. / Lens, S. / Mariño, Z. / Lodoño, M.C. / del Pulgar, S.P. / Costa, J. / Sanchez-Tapias, J.M. / Forns, X. et al. | 2017
- S255
-
Outcome in chronic hepatitis delta: differences between African and non-African patientsSpaan, M. / Carey, I. / Wang, B. / Shang, D. / Horner, M. / Bruce, M. / Dusheiko, G. / Agarwal, K. et al. | 2017
- S256
-
Update on safety and efficacy in the REP 401 protocol: REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infectionBazinet, M. / Pantea, V. / Placinta, G. / Moscalu, I. / Cebotarescu, V. / Cojuhari, L. / Jimbei, P. / Iarovoi, L. / Smesnoi, V. / Musteata, T. et al. | 2017
- S257
-
Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International networkWranke, A. / Hardtke, S. / Borzacov, L.M.P. / Parana, R. / Lobato, C. / Hamid, S. / Ceausu, E. / Dalekos, G.N. / Rizzetto, M. / Turcanu, A. et al. | 2017
- S258
-
Viral kinetics in women of child bearing potential with chronic hepatitis B virus following treatment with tenofovir alafenamide or tenofovir disoproxil fumaratePan, C. / Chang, T.-T. / Bae, S.-H. / Brunetto, M. / Coffin, C. / Lau, A. / Mo, S. / Flaherty, J.F. / Gaggar, A. / Subramanian, G.M. et al. | 2017
- S259
-
On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHBWong, D. / Littlejohn, M. / Yuen, L. / Jackson, K. / Mason, H. / Gaggar, A. / Kitrinos, K. / Subramanian, M. / Marcellin, P. / Buti, M. et al. | 2017
- S261
-
Hepatitis B virus basal core promotor variants become selected in serum hepatitis B virus DNA but not in hepatitis B virus RNA genome in patients responding to treatment with peginterferon-alfa 2a (PEG-IFNα)Grossmann, M. / Deichsel, D. / Pavlovic, V. / He, H. / Wat, C. / Hahn, C. / Berg, T. / Van Boemmel, F. et al. | 2017
- S262
-
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technologyCaviglia, G.P. / Abate, M.L. / Olivero, A. / Rosso, C. / Ciancio, A. / Bugianesi, E. / Saracco, G.M. / Smedile, A. et al. | 2017
- S263
-
Experiences from one of the largest treatment programs for chronic hepatitis B in sub-Saharan AfricaDesalegn, H. / Aberra, H. / Berhe, N. / Gundersen, S.G. / Johannessen, A. et al. | 2017
- S265
-
Dissociation of temporal trends in mortality from liver disease and liver cancer in a hepatitis B virus-endemic population: 1999–2013Choi, J. / Han, S. / Kim, N. / Lim, Y.-S. et al. | 2017
- S266
-
Rising healthcare utilization and cost of chronic hepatitis B: real-world analysis of 44,026 chronic hepatitis B patients and 121,568 matched non-chronic hepatitis B controls in the United StatesLim, J. / Nguyen, M. / Liou, I. / Ozbay, A.B. / Moore-Schiltz, L. / Dusheiko, G. / Gordon, S. et al. | 2017
- S267
-
Change in the trajectory of MELD scores in liver transplant candidates with hepatitis C in the direct acting antiviral eraKwong, A. / Mannalithara, A. / Kim, D. / Kim, W.R. et al. | 2017
- S268
-
Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based surveyAndriulli, A. / Stroffolini, T. / Valvano, M.R. / Grattagliano, I. / Ippolito, A.M. / Grossi, A. / Brancaccio, G. / Coco, C. / Russello, M. / Smedile, A. et al. | 2017
- S269
-
High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatmentBowing, A.L. / Doyle, J.S. / Iser, D.M. / Sasadeusz, J. / Roney, J. / O’Reilly, M. / Fairley, C. / Gane, E. / Hoy, J. / Matthews, G.V. et al. | 2017
- S270
-
Low hepatitis C virus prevalence among human immunodeficiency virus+ individuals in Sub-Saharan AfricaLoarec, A. / Molfino, L. / Walter, K. / Muyindike, W. / Carnimeo, V. / Andrieux-Meyer, I. / Balkan, S. / Nzomukunda, Y. / Maman, D. / Mwanga-Amumpaire, J. et al. | 2017
- S271
-
An audit of hepatitis C screening and referral patterns to a specialist hepatology service in a secondary care facility in the UKShearer, J. / Pratt, A. / Hutchinson, J. / Todd, N. / Millson, C. et al. | 2017
- S272
-
High incidence of persistently altered liver tests after sustained virological response with direct-acting antiviral in hepatitis C monoinfected and HIV-coinfected patientsMontes, M. / Domínguez, L. / Castillo, P. / García-Samaniego, J. / Martín-Carbonero, L. / Valencia, E. / Moreno, V. / Larrubia, J.R. / Romero, M. / García, A. et al. | 2017
- S273
-
Large-scale screening is not useful to identify individuals with hepatitis B or C virus infection: results of an interim analysisMarot, A. / Trabelsi, A. / André, C. / Deltenre, P. et al. | 2017
- S275
-
The number of small low-density lipoprotein particles is decreased by hepatitis C virus G1b infectionKinoshita, C. / Nagano, T. / Seki, N. / Hokari, A. / Aizawa, Y. et al. | 2017
- S276
-
Characterisation of resistance associated substitutions in direct acting antivirals treatment naive patients with genotype 3 hepatitis C virusSmith, D.A. / Magri, A. / Bonsall, D. / Ansari, M.A. / Ip, C. / Trebes, A. / Brown, A. / Piazza, P. / Bowden, R. / Klenerman, P. et al. | 2017
- S277
-
Understanding factors associated with hepatitis c spontaneous viral clearance: a meta-analysisAisyah, D.N. / Shallcross, L. / Hully, A.J. / Hayward, A. et al. | 2017
- S278
-
Rate and predictive factors of spontaneous hepatitis C virus clearance after acute infection in human immunodeficiency virus-positive subjectsMerli, M. / Galli, L. / Poli, A. / Salpietro, S. / Messina, E. / Parisi, M.R. / Andolina, A. / Morsica, G. / Bagaglio, S. / Castagna, A. et al. | 2017
- S279
-
Performance of the validated EGCRISC screening tool in chronic hepatitis C infection detection after application in the Egyptian settingEl-Ghitany, E.M. / Farghaly, A. / Farag, S. et al. | 2017
- S280
-
Factors that influence the improvement of serum albumin during interferon-free sofosbuvir/ledipasvir therapy for Japanese patients with chronic hepatitis C virus infectionKawano, A. / Ogawa, E. / Furusyo, N. / Nomura, H. / Dohmen, K. / Higashi, N. / Takahashi, K. / Azuma, K. / Satoh, T. / Nakamuta, M. et al. | 2017
- S281
-
Impact of IL28B genotype on response rates in hepatitis C virus cirrhotic patients treated with new DAA regimens: experience of a single centerPonzo, P. / Troshina, G. / Tucci, A. / Venezia, L. / Sacco, M. / Smedile, A. / Abate, M.L. / Caviglia, G. / Olivero, A. / Rizzetto, M. et al. | 2017
- S282
-
Risk of cardiovascular and cerebrovascular events in hepatitis C patients following completion of direct-acting antiviral therapy: a retrospective cohort studySinger, A.W. / Osinusi, A. / Brainard, D.M. / Chokkalingam, A.P. et al. | 2017
- S283
-
SVR reduces ethnic disparities in progression to advanced liver disease in patients with chronic hepatitis CLe, A.K. / Zhao, C. / Hoang, J. / Yasukawa, L.A. / Zhang, J. / Weber, S.C. / Nguyen, M. et al. | 2017
- S284
-
Efficacy and safety of paritaprevir/ritonavir, ombitasvir and dasabuvir plus/minus ribavirin for treatment of hepatitis C virus genotype 1b compensated cirrhosis in patients aged 70 years or olderTrifan, A. / Prelipcean, C.C. / Gheorghe, L. / Curescu, M.G. / Brisc, C. / Bataga, S. / Miftode, E. / Arama, V. / Chiriac, S.A. / Cuciureanu, T. et al. | 2017
- S286
-
Liver stiffness evaluated by means of ARFI is related not only to fibrosis in patients with hepatitis C virus-related chronic hepatitisGesualdo, A. / D’Alitto, F. / Ricci, L. / Di Gennaro, C. / Settimo, E. / Palmieri, V.O. et al. | 2017
- S289
-
High sustained virological response rates in hepatitis C genotypes 1a and 4 patients treated with elbasvir and grazoprevir and basal viremia >800.000 UI/mLOlveira, A. / Montes, M. / Navas, A.L. / García-Samaniego, J. / Martín-Carbonero, L. / Larrubia, J.R. / Castillo, P. / Madejón, A. / Romero, M. / García, A. et al. | 2017
- S290
-
The effect of directly acting antivirals treatment on inflammatory status in HCV-infected patients, including those with recurrence of HCV-infection after liver transplantation: preliminary results of a prospective monocentric pilot studyLattanzi, B. / Baroncelli, S. / Palmisano, L. / Galluzzo, C.M. / Michelini, Z. / Lupo, M. / De Santis, A. / Corradini, S.G. / Mennini, G. / Rossi, M. et al. | 2017
- S291
-
The path towards hepatitis C elimination in Australia following universal access to interferon-free treatmentsHajarizadeh, B. / Grebely, J. / Matthews, G.V. / Martinello, M. / Dore, G.J. et al. | 2017
- S292
-
Grazoprevir-elbasvir based therapy is safe and effective in patients with chronic kidney disease GFR < 30 and patients with end stage renal disease who are on renal replacement therapy in a community based settingYanny, B. / Sahota, A. et al. | 2017
- S293
-
Using all-oral hepatitis C virus therapy to reduce recurrent viremia and increase SVRAlimohammadi, A. / Raycraft, T. / Shahi, R. / Singh, A. / Kiani, G. / Conway, B. et al. | 2017
- S294
-
Feasibility and acceptability of a group medical visit intervention to improve hepatitis C virus treatment uptake among persons who inject drugs (PWID) in a primary care settingNorton, B. / McMurry, C. / Gover, M. / Cunningham, C. / Litwin, A. et al. | 2017
- S295
-
Outcome of patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort studyPreda, C. / Popescu, C. / Constantinescu, I. / Manuc, M. / Tugui, L. / Voiosu, R. / Ceausu, E. / Diculescu, M. / Oproiu, A. et al. | 2017
- S296
-
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysisChen, G.F. / Wang, C. / Chen, J. / Ji, D. / Shao, Q. / Li, F. / Li, B. / Wu, V. / Wong, A. / Wang, Y.D. et al. | 2017
- S297
-
Clinically meaningful differences in health-related quality of life and fatigue in patients with hepatitis C virus infection treated with elbasvir/grazoprevir compared to sofosbuvir with pegylated interferon and ribavirinNwankwo, C. / King-Kallimanis, B. / Corman, S. / Qiu, J. / Patel, S. / Arduino, J.M. / Platt, H.L. / Sperl, J. et al. | 2017
- S298
-
Projected long term impact of elbasvir/grazoprevir compared to sofosbuvir plus pegylated interferon/ribavirin in chronic hepatitis C virus genotype 1 and 4 patients in Italy: translation of the C-EDGE Head-2-Head study findingsNwankwo, C. / Batterson, R. / Todd, E. / Jiang, Y. / Platt, H.L. / Meng, Y. et al. | 2017
- S299
-
Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 InfectionHezode, C. / Leroy, V. / Rosa, I. / Roudot-Thoraval, F. / Pawlotsky, J.-M. / de Ledinghen, V. / Bronowicki, J.-P. et al. | 2017
- S300
-
ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/ paritaprevir/ritonavir ± dasabuvir ± ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infectionLeung, D.H. / Yao, B. / Viani, R.M. / Gonzalez-Peralta, R.P. / Jonas, M.M. / Lobritto, S.J. / Narkewicz, M.R. / Sokal, E. / Fortuny, C. / Hsu, E. et al. | 2017
- S301
-
Real world efficacy of 12 weeks sofosbuvir, daclastivir with ribavirin among cirrhotic pre and post-transplant genotype 3 hepatitis C infected patientsSchmidt-Martin, D. / Bufton, S. / Roberts, M. / Rye, K. / Singhal, S. / Eldred, S. / Perry, I. / Corbett, C. / Unitt, E. / Wood, V. et al. | 2017
- S301
-
Effects of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection on serotonin metabolism, depression scores and fatigueHahn, D. / Stokes, C.S. / Kaiser, R. / Meyer, M.R. / Lammert, F. / Grünhage, F. et al. | 2017
- S302
-
Treatment outcomes of hepatitis C virus recombinant form 2k/1b with sofosbuvir based regimens in GeorgiaZakalashvili, M. / Zarkua, J. / Weizenegger, M. / Bartel, J. / Raabe, M. / Telia, T. / Zhamutashvili, M. / Metreveli, S. / Barnova, M. / Abramishvili, N. et al. | 2017
- S305
-
Prospective study of autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct acting antiviralsFernández, D.A. / Suñer, M.A. / Iglesias, M.J.F. / Nuñez, C.L. / Matamala, I.S. / Molés, X.Q. / Mante, X.A. et al. | 2017
- S306
-
High sustained virologic response rates in patients with chronic hepatitis C virus GT1, 2 or 3 infection following 16 weeks of MK-3682/grazoprevir/ruzasvir plus ribavirin after having failed 8 weeks of a triplet drug regimen (Part C of C-CREST-1 & 2)Serfaty, L. / Pianko, S. / Ari, Z.B. / Laursen, A.L. / Hansen, J. / Gane, E.J. / Huang, H.-C. / Jin, S. / Bourque, J. / Liu, H. et al. | 2017
- S307
-
Real-world utilization of the new fixed-dose combination elbasvir/grazoprevir in adult patients with chronic hepatitis C in Canada: Z-PROFILE studyTam, E. / Fraser, C. / Tremblay, J. / Conway, B. / Trottier, B. / Ramji, A. / Borgia, S. / Stewart, K. / Trépanier, J. / Chalabi, Y. et al. | 2017
- S308
-
High efficacy of 8 weeks of ledipasvir/sofosbuvir in real-world treatmentTang, L. / Parker, A. / Flores, Y. / Dellario, M. / Dickson, C. / Amoroso, A. / Kottilil, S. / Wilson, E. et al. | 2017
- S309
-
Improvement of glycemic state among responders to sofosbuvir – based DAAsAlem, S.A. / Fouad, R. / Elsharkawy, A. / Adel, E. / Abdellatif, Z. / Musa, S. / Nagy, A. / Hussein, M.S. / Yosry, A. / Esmat, G. et al. | 2017
- S310
-
Treatment with SOF/VEL or SOF/VEL/VOX is well tolerated and results in high SVR12 in genotype 1–6 HCV infected patients with minimal fibrosis: a retrospective analysis of the ASTRAL and POLARIS clinical studiesLawitz, E. / Bourlière, M. / Han, L. / Mcnally, J. / Stamm, L.M. / Brainard, D.M. / Subramanian, G.M. / Flamm, S.L. / Reddy, K.R. et al. | 2017
- S311
-
Evolution of platelets in chronic hepatitis C infected patients and advanced liver fibrosis after direct-acting antiviral treatmentSáez-Royuela, F. / Linares, P. / Calvo, S. / Martín, I. / Almohalla, C. / Jorquera, F. / Ramos, H. / De Benito, M. / Bernad, B. / Alvarez, B. et al. | 2017
- S314
-
Successful management of drug interactions with ritonavir-containing hepatitis C virus regimens in routine clinical practiceMarra, F. / Boyle, A. / Fox, R. / Fleming, C. / Reilly, E. / Heydtmann, M. / Datta, S. / Priest, M. / Barclay, S.T. et al. | 2017
- S315
-
Efficacy and safety of the fixed-dose combination regimen of MK3 [MK-3682/grazoprevir/ruzasvir] with or without ribavirin in non-cirrhotic or cirrhotic patients with chronic HCV GT1, 2, 3, 4 or 6 infection (Parts A & B of C-CREST-1 & 2)Lawitz, E. / Yoshida, E.M. / Buti, M. / Vierling, J.M. / Almasio, P.L. / Bruno, S. / Ruane, P.J. / Hassanein, T.I. / Mullhaupt, B. / Pearlman, B. et al. | 2017
- S316
-
Chronic hepatitis C in children in the Russian Federation: a multicenter studyVolynets, G.V. / Skvortsova, T.A. / Potapov, A.S. / Panfilova, V.N. / Rogozina, N.V. / Nikitin, A.V. / Giaquinto, C. / Thorne, C. / Turkova, A. et al. | 2017
- S318
-
DC-SIGN polymorphisms associate with sexual hepatitis C virus transmission and DC-SIGN m-RNA expression levelsSteba, G.S. / Koekkoek, S.M. / Vanhommerig, J.W. / Brinkman, K. / van der Meer, J.T.M. / Prins, M. / Paxton, W.A. / Molenkamp, R. / Schinkel, J. et al. | 2017
- S319
-
Allelic variantes of Aurora B kinase gene can be related with fibrosis progression in chronic hepatitis CFrancisco-Recuero, I. / Gil, A.I. / Madejón, A. / Sánchez-Pacheco, A. / Romero, M. / García, A. / Olveira, A. / Castillo, P. / Erdonzaín, J.C. / Perales, C. et al. | 2017
- S320
-
Hepatocyte single cell sequencing to identify transcript modulation by hepatitis C virusDebes, J.D. / Reilly, C. / van Oord, G. / Bohjanen, P.R. / vanwolleghem, T. / Boonstra, A. et al. | 2017
- S321
-
Identification of glycogen synthase kinase 3 beta as a novel host factor of hepatitis C virus replicationSaleh, M. / Rüschenbaum, S. / Welsch, C. / Zeuzem, S. / Moradpour, D. / Gouttenoire, J. / Lange, C.M. et al. | 2017
- S322
-
MIV-802, a uridine nucleotide prodrug, is a more potent inhibitor of hepatitis C virus genotype 3 replication than sofosbuvirLana, E. / Brenndörfer, E. / Kylefjord, H. / Eneroth, A. / Pinho, P. / Rosenquist, Å. / Targett-Adams, P. / Bethell, R. et al. | 2017
- S323
-
Hepatitis C virus-induced MiR-21 activation triggers steatosis and promotes hepatitis C virus life cycleClément, S. / Sobolewski, C. / Rojas, A. / Bonifacio, G. / Goossens, N. / Conzelmann, S. / Gomes, D. / Calo, N. / Negro, F. / Foti, M. et al. | 2017
- S324
-
Exosomal miRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infectionQi, Z. / Qian, X. / Xu, C. / Fang, S. / Zhao, P. / Wang, Y. / Liu, H. / Yuan, W. et al. | 2017
- S326
-
MAIT cell frequency and function in blood and liver of hepatitis C virus mono- and hepatitis C virus/human immunodeficiency virus co-infected patients with mild versus advanced fibrosisBeudeker, B. / van Oord, G. / Arends, J. / zur Wiesch, J.S. / de Knegt, R. / Verbon, A. / Boonstra, A. / Claassen, M. et al. | 2017
- S327
-
Hepatitis B virus affects dendritic cell activation and their crosstalk with natural killer cellsDe Pasquale, C. / Campana, S. / Barberi, C. / Raimondo, G. / Pollicino, T. / Ferlazzo, G. et al. | 2017
- S328
-
N22 region based dot blot assay: an alternative to PCR for detection of Torque teno virus infectionMankotia, D.S. / Joshi, Y.K. / Irshad, M. et al. | 2017
- S330
-
Targeting NF-KappaB dependent intrinsic innate immune pathways activated by DNA and hepatitis B virus to facilitate in vitro hepatitis b virus infectionYoneda, M. / Hyun, J. / Schiff, E. / Thomas, E. et al. | 2017
- S333
-
A protective role of IL-22BP in acute liver injuryKleinschmidt, D. / Giannou, A.D. / Kempski, J. / Steglich, B. / Huber, F.J. / Shiri, A.M. / Tiegs, G. / Gagliani, N. / Huber, S. et al. | 2017
- S334
-
Combining renewable human liver tissue and novel extracorporeal devices to deliver mammalian liver supportRashidi, H. / Dunphy, S. / Ginai, M. / Dong, H. / Alwahsh, S. / Luu, N.T. / Newsome, P. / Forbes, S. / Bradley, M. / Callanan, A. et al. | 2017
- S335
-
The Role of chemokine (C-C motif) ligand 2 and the diet influence in the energy metabolismLuciano, F. / Cabré, N. / Hernandez-Aguilera, A. / Baiges-Gaya, G. / Garcia-Heredia, A. / Fernández-Arroyo, S. / Camps, J. / Joven, J. et al. | 2017
- S336
-
IL-33 protects Murine viral fulminant hepatitis by targeting coagulation hallmark protein Fgl2/Fibroleukin expressionYu, H. / Liu, Y. / Wang, H. / Yan, W. / Huang, J. / Luo, X. / Ning, Q. et al. | 2017
- S337
-
Formation of bile canaliculi in liver progenitor cell-derived hepatocytes determines clinical outcome of acute-on-chronic liver failureYuan, X. / Gu, W. / Wandrer, F. / Dewidar, B. / Munker, S. / Hähnel, B. / Liebe, R. / Ebert, M.P. / Qiang, X. / Bantel, H. et al. | 2017
- S338
-
The hepatoprotective cytokine Cardiotrophin-1 (CT-1) attenuates inflammation and prevents the systemic effects of endotoxemia by promoting M2 macrophage polarizationVélez-Qrtiz, J.M. / María, E.S. / Larequi, E. / Colodrero, P. / Reboredo, M. / Muntané, J. / Padillo, F.J. / Prieto, J. / Hervás-Stubb, S. / Bustos, M. et al. | 2017
- S340
-
Long term mortality is increased in patients surviving acute liver failure without liver transplantationDonnelly, M.C. / Williams, L. / Murray, B. / Taylor, C. / Springbett, A. / Davidson, J. / Baird, A. / Martin, K. / Moore, J.K. / Lone, N. et al. | 2017
- S341
-
Melatonin protects liver in experimental severe acute liver failureMarroni, N.A.P. / Salvi, J.D.O. / Schemitt, E.G. / Colares, J.R. / Hartmann, R.M. / Licks, F. / Santos, V.F.L.D. / Marroni, C.A. et al. | 2017
- S342
-
Multi-state modelling of progression from acute liver failure to intracranial hypertension and deathBjerring, P.N. / Larsen, F.S. et al. | 2017
- S343
-
External validation of the USALFSG acute liver failure outcome prediction criteriaBernal, W. / Donnelly, M.C. / Durkalski-Mauldin, V.L. / Simpson, K. / Wang, Y. / Wendon, J. et al. | 2017
- S344
-
Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: a prospective studyLouvet, A. / Labreuche, J. / Artru, F. / Bouthors, A. / Rolland, B. / Saffers, P. / Dharancy, S. / Lassailly, G. / Canva-Delcambre, V. / Duhamel, A. et al. | 2017
- S345
-
Variation in the use of corticosteroids for the treatment of acute severe alcoholic hepatitis in the post-STOPAH era: results of a UK national surveyDhanda, A. / Atkinson, S. / Thursz, M. et al. | 2017
- S347
-
Effect of alcohol on the IL-6 mediated inflammatory response in a new mouse model of acute-on-chronic liver injuryKaratayli, E. / Hall, R.A. / Dooley, S. / Lammert, F. et al. | 2017
- S348
-
Differential gender-related impact of PNPLA3 and CD14 polymorphism on the risk of developing alcoholic cirrhosisMischitelli, M. / Mancina, R. / Ferri, F. / Farcomeni, A. / Molinaro, A. / Maffongelli, A. / Poli, E. / Rotondo, C. / Codazzo, C. / Galli, D. et al. | 2017
- S349
-
Carcinogenic Etheno DNA -adducts in alcohol liver disease: correlation with cytochrome P-4502E1 and fibrosisSeitz, H.K. / Pecerella, T. / Flechtenmacher, C. / Straub, B.K. / Stickel, F. / Bruckner, T. / Bartsch, H. / Mueller, S. / Peccerella, T. et al. | 2017
- S350
-
Effects of probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) in the treatment of mild alcoholic hepatitis: randomized controlled multicenter studySuk, K.T. / Kim, D.J. / Yang, Y.J. / Hong, M. / Kim, S.E. / Park, J.W. / Kim, H.S. / Jang, M.K. / Park, C.K. et al. | 2017
- S352
-
The role of ethnicity in autoimmune hepatitisGerussi, A. / Halliday, N. / Roccarina, D. / Saffioti, F. / Polly, P. / Marshall, A. / Thorburn, D. et al. | 2017
- S353
-
Evaluation of 6-thioguanine therapy in autoimmune hepatitisvan den Brand, F.F. / de Boer, Y.S. / Verwer, B.J. / Bloemena, E. / de Boer, N. / Mulder, C.J. / van Nieuwkerk, C.M. / Bouma, G. et al. | 2017
- S354
-
Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP)Blesl, A. / Horvath, A. / Jüngst, C. / Leber, B. / Schmerboeck, B. / Tawdrous, M. / Stiegler, P. / Rainer, F. / Spindelboeck, W. / Fickert, P. et al. | 2017
- S355
-
The novel hexokinase 1 antibodies are useful for the diagnosis and associated with bad prognosis in primary biliary cholangitisReig, A. / Garcia, M. / Shums, Z. / Milo, J. / Encabo, S. / Bentow, C. / Mahler, M. / Romera, M.A. / Viñas, O. / Norman, G.L. et al. | 2017
- S356
-
Prompt initiation of intravenous corticosteroids prevents deterioration of acute/severe autoimmune hepatitis (AS-AIH) and the need for liver transplantation (LT)Zachou, K. / Arvaniti, P. / Gatselis, N.K. / Azariadi, K. / Koukoulis, G.K. / Dalekos, G.N. et al. | 2017
- S360
-
Prospective validation of serum alkaline phosphatase for the prediction of disease progression in a randomized trial of patients with primary sclerosing cholangitisLevy, C. / Eksteen, B. / Shiffman, M. / Janssen, H. / Montano-Loza, A. / Ding, D. / Jia, C. / Mccolgan, B. / Myers, R. / Subramanian, M. et al. | 2017
- S361
-
Autoimmune Hepatitis with normal IgG levels at diagnosis: subtype with a higher rate of successful treatment withdrawal?Hartl, J. / Asghar, A. / Wong, G.W. / Pape, S. / Lohse, A.W. / Drenth, J.P. / Oo, Y.H. / Michael, H.A. / Schramm, C. et al. | 2017
- S363
-
Macrophage migration inhibitory factor (MIF) modulates T-cell proliferation and hepatic inflammation in a model of autoimmune liver diseaseRoberts, S. / Leng, L. / Soroka, C.J. / Boyer, J.L. / Bucala, R. / Assis, D.N. et al. | 2017
- S364
-
Obeticholic acid therapy improves cognitive decline in cholestatic liver diseaseMillar, B. / Richardson, C. / McKay, K. / Pechlivanis, A. / Innes, B. / Kirby, J. / Jones, D. / Holmes, E. / Oakley, F. et al. | 2017
- S365
-
Magnetic resonance imaging findings are related with serum and endoscopic markers of disease activity and severity in primary sclerosing cholangitisTenca, A. / Lind, K. / Lantto, E. / Mustonen, H. / Kolho, K.-L. / Boyd, S. / Arola, J. / Farkkila, M. et al. | 2017
- S366
-
Sortilin regulates ductular reaction and bile duct morphogenesis in cholestasis-induced liver injury via IL-6 and LIFZvibel, I. / Hubel, E. / Avraham, R. / Shibolet, O. et al. | 2017
- S367
-
Exhaustive blood immune phenotype of patients with autoimmune hepatitisRenand, A.P. / Judor, J.-P. / Aublé, H. / Archambeaud, I. / Mosnier, J.-F. / Gournay, J. / Brouard, S. / Conchon, S. et al. | 2017
- S368
-
Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosisRainer, F. / Horvath, A. / Sandahl, T.D. / Leber, B. / Schmerboeck, B. / Blesl, A. / Krones, E. / Baumann-Durchschein, F. / Douschan, P. / Spindelboeck, W. et al. | 2017
- S369
-
3 times higher healthcare cost in chronic hepatitis B patients compared to non-chronic hepatitis B controls especially those with decompensated liver disease: United States real world healthcare utilization and cost analysisNguyen, M.H. / Lim, J. / Ozbay, A.B. / Shreay, S. / Liou, I. / Meyer, N. / Dusheiko, G. / Gordon, S. et al. | 2017
- S370
-
Abnormal MOCA scores are common and predict morbidity and mortality in patients with cirrhosisNey, M. / Bhardwaj, P. / Dobbs, B. / Ma, M. / Bailey, R.J. / Abraldes, J. / Rolfson, D. / Tandon, P. et al. | 2017
- S371
-
Hepatic encephalopathy in cirrhotic patients with bacterial infections: prevalence, clinical characteristics and correlation with prognosis: a prospective studyPiedade, J. / Guimarães, L. / Rocha, T. / Victor, L. / Baldin, C. / Rodrigues, B. / Veiga, Z. / Agoglia, L. / Fernandes, F. / Pereira, G.H.S. et al. | 2017
- S372
-
Palliative care access for hospitalized patients with end stage liver disease across the United StatesRush, B. / Walley, K. / Celi, L.A. / Rajoriya, N. / Brahmania, M. et al. | 2017
- S373
-
Von Willebrand factor antigen predicts portal hypertensive bleeding, infections, and survival, independently of portal hypertension severityMandorfer, M. / Schwabl, P. / Bucsics, T. / Paternostro, R. / Pomej, K. / Ay, J. Thaler C. / Quehenberger, P. / Trauner, M. / Peck-Radosavljevic, M. / Reiberger, T. et al. | 2017
- S374
-
Comparison of efficacy of cefotaxime, ceftriaxone, and ciprofloxacin for the treatment of spontaneous bacterial peritonitis in patients with liver cirrhosis: a randomized controlled trialYim, H.J. / Suh, S.J. / Jung, Y.K. / Kim, M.Y. / Baik, S.K. / Kim, H.S. / Kim, Y.S. / Park, S.Y. / Kim, B.I. / Park, J.Y. et al. | 2017
- S375
-
A multimodality assessment of liver fibrosis in asymptomatic Fontan patientsMunsterman, I. / Duijnhouwer, T. / Bronckhorst, C. / Drenth, J. / van Dijk, A. / Tjwa, E. et al. | 2017
- S377
-
An Innovative app focused on patients and caregivers significantly decreases avoidable and HE-related readmissions in cirrhotic patientsGanapathy, D. / Lachar, J. / Acharya, C. / White, M. / Sterling, R.K. / Matherly, S. / Puri, P. / Stravitz, R.T. / Siddiqui, M.S. / Sanyal, A.J. et al. | 2017
- S378
-
Oral glutamine challenge predicts risk and defines hepatic encephalopathy typesAmpuero, J. / Gómez, A.G. / Del Mar Viloria, M. / Camacho, I. / Moro, A. / Romero-Gomez, M. et al. | 2017
- S379
-
The Quick SOFA, a simple bedside score, identifies hospitalized cirrhotic patients with poor outcomesCervoni, J.-P. / Weil, D. / Bureau, C. / Oberti, F. / Anty, R. / Louvet, A. / Plessier, A. / Rudler, M. / Heurgué-Berlot, A. / Rosa, I. et al. | 2017
- S380
-
Performance of upper gastrointestinal bleeding risk assessment scores in variceal bleeding: a prospective international multicenter studyNgu, J.H. / Laursen, S.B. / Chin, Y.K. / Laine, L. / Dalton, H.R. / Murray, I.A. / Schultz, M. / Nadkarni, N.V. / Stanley, A.J. et al. | 2017
- S381
-
Acute hemodynamic response to beta-blockers: factors influencing its outcomeFortea, J.I. / Puente, A. / Ruiz, P. / Arias-Loste, M.T. / Alvarez, S. / Cabezas, J. / Cuadrado, A. / Llerena, S. / Estébanez, A. / Casafont, F. et al. | 2017
- S382
-
Medication beliefs predict low medication adherence in people with decompensated cirrhosisHayward, K.L. / Valery, P.C. / Martin, J.H. / Karmakar, A. / Patel, P.J. / Horsfall, L.U. / Irvine, K.M. / Stuart, K.A. / Tallis, C.J. / Wright, P.L. et al. | 2017
- S383
-
Presence of ACLF is the best predictor of mortality in patients with decompensated chronic liver disease managed in a non-specialist environmentBurke, L. / Lane, C. / Gao-Du, Y. / Driver, R. / Corless, L. et al. | 2017
- S384
-
Rifaximin-α is associated with reductions in emergency department resource use in UK patients with hepatic encephalopathy: real world evidence from the IMPRESS studyHudson, M. / Di Maggio, P. / Cipelli, R. / Aspinall, R. et al. | 2017
- S385
-
Cellulitis is a common precipitant of acute kidney injury and mortality in patients with cirrhosisde Paredes, A.G.G. / Téllez, L. / Rodríguez-Gandía, M.Á. / Martínez, J. / Gea, F. / Albillos, A. et al. | 2017
- S387
-
Effect of terlipressin treatment in liver transplant-eligible patients with hepatorenal syndromeNguyen-Tat, M. / Häring, M.-T. / Zimmermann, T. / Nagel, M. / Weinmann-Menke, J. / Rey, J.W. / Wörns, M.A. / Galle, P.R. / Marquardt, J.U. et al. | 2017
- S388
-
Abnormalities in skin temperature and its 24-hour rhythm in patients with cirrhosis: sleep-wake and general clinical implicationsGarrido, M. / Saccardo, D. / De Rui, M. / Vettore, E. / Verardo, A. / Carraro, P. / Di Vitofrancesco, N. / Mani, A.R. / Angeli, P. / Bolognesi, M. et al. | 2017
- S389
-
Glutamine synthetase in endothelial cells of the blood-brain barrier: less but not insignificant?Oliveira, M.M. / Tremblay, M. / Rose, C.F. et al. | 2017
- S390
-
Survival predictors in cirrhotic patients with refractory ascites treated with transjugular intrahepatic portosystemic shuntAicart-Ramos, M. / Ibáñez-Samaniego, L. / Martínez-Lozano, H. / Catalina, M.-V. / Rodríguez-de Santiago, E. / Bañares, R. / Albillos, A. et al. | 2017
- S391
-
Cannabinoid receptor 1 mediates M1 polarization of bone marrow-derived monocytes/macrophages via RhoA/NF-κB p65 and ERK1/2 signaling pathways respectively in mouse fibrotic liverTian, L. / Yang, L. / Li, W. / Fan, X. / Yang, J. / Chang, N. / Xie, J. / Li, L. et al. | 2017
- S392
-
Systemic delivery of gene therapy – a proof of concept study in a model of cirrhosis and portal hypertensionJones, H. / Habtesion, A. / Mehta, G. / Jalan, R. / Davies, N.A. / Mookerjee, R.P. et al. | 2017
- S393
-
Inhibition of macrophage infiltrations by thalidomide improves muscle wasting of cirrhotic ratsLin, H.-C. / Li, T.-H. / Lee, P.-C. / Liu, W.-C. / Huang, S.-F. / Lee, K.-C. / Hou, M.-C. / Yang, Y.-Y. et al. | 2017
- S394
-
Vascular morphology alterations during liver cirrhogenesis in ratsPeeters, G. / Debbaut, C. / De Vos, W.H. / Cornillie, P. / De Schryver, T. / Monbaliu, D. / Laleman, W. / Segers, P. et al. | 2017
- S395
-
Alpha Toocotrienol causes apoptosis of activated Hepatic Stelate cells through lysosome mitochondrial axis in INH induced liver fibrosis: an in-vitro studySantra, S. / Chowdhury, A. / Bishnu, D. / Dhali, G.K. / Santra, A. et al. | 2017
- S396
-
The novel macrophage activation marker soluble Mannose Receptor, and soluble CD163, are elevated after acetaminophen intoxication in relation to liver disease severitySiggaard, C.B. / Kazankov, K. / Møller, H.J. / Donnelly, M.C. / Simpson, K.J. / Grønbæk, H. et al. | 2017
- S397
-
p62/sqstm1 in a drug-induced model of hepatotoxicity: a novel role beyond autophagyAlegre, F. / Polo, M. / Marti-Rodrigo, A. / Moragrega, A.B. / Esplugues, J.V. / Blas-Garcia, A. / Apostolova, N. et al. | 2017
- S398
-
Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity in miceTeratani, T. / Tomita, K. / Suzuki, T. / Furuhashi, H. / Irie, R. / Hida, S. / Okada, Y. / Kurihara, C. / Ebinuma, H. / Nakamoto, N. et al. | 2017
- S399
-
Prevalence and severity of liver injury after pulsed methylprednisolone therapy in multiple sclerosis patientsBiolato, M. / Nociti, V. / Marrone, G. / Liguori, A. / De Fino, C. / Bianco, A. / Mirabella, M. / Grieco, A. et al. | 2017
- S401
-
Influence of host characteristics and pharmacological properties on type of liver injury in hepatotoxicityGonzalez-Jimenez, A. / Chen, M. / McEuen, K. / Stephens, C. / Medina-Caliz, I. / Robles-diaz, M. / Slim, M. / Lucena, M.I. / Suzuki, A. / Andrade, R. et al. | 2017
- S403
-
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infectionPallarés, C. / Carvalho-Gomes, A.S. / Conde, I. / Di Maira, T. / Hontangas, V. / Aguilera, V. / López-Labrador, F.X. / Berenguer, M. et al. | 2017
- S404
-
Screening for HCV in pregnant women and their partnersMillbourn, C. / Lybeck, C. / Fadl, H. / Fredlund, H. / Lindahl, K. / Duberg, A.-S. et al. | 2017
- S405
-
HCV elimination among people who inject drugs. What would happen after the WHO HCV elimination target is achieved?Gountas, I. / Gamkrelidze, I. / Pasini, K. / Blach, S. / Razavi-Shearer, D. / Estes, C. / Razavi, H. et al. | 2017
- S406
-
Treatment and primary prevention in people who inject drugs (PWID) for chronic Hepatitis C (CHC): is elimination possible in a high prevalence setting?Gountas, I. / Sypsa, V. / Anagnostou, O. / Martin, N. / Vickerman, P. / Kafetzopoulos, E. / Hatzakis, A. et al. | 2017
- S408
-
Do elevated liver values necessarily indicate a health problem or could poorly defined upper limits of normal be an issue? Alanine aminotransferase and gamma-glutamyltransferase depend strongly on ageWiegand, J. / Petroff, D. / Bätz, O. / Jedrysiak, K. / Kramer, J. / Wolffram, I. / Berg, T. et al. | 2017
- S409
-
Smoking and metabolic syndrome components are independent predictors of mortality in patients with chronic liver disease in the United StatesWijarnpreecha, K. / Scribani, M. / Ungprasert, P. / Merrell, N. / Raymond, P. et al. | 2017
- S410
-
Chronic hepatitis C diagnosis increases sick leave and disability pensionBuesch, K. / Hansson, F. / Holton, M. / Lagging, M. / Westin, J. / Kövamees, J. / Sällberg, M. / Söderholm, J. et al. | 2017
- S412
-
Hepatitis prevention, control, and elimination program in Mongolia: national hepatitis elimination program in a country with the highest burden of viral hepatitis in the worldDashdorj, N. / Bungert, A.S. / Genden, Z. / Dendev, B. / Duger, D. / Dagvadorj, A. / Yagaanbuyant, D. et al. | 2017
- S413
-
Implementing the WHO Global Health Sector Strategy on Viral Hepatitis in Denmark – modeling the effects of community-based care on the elimination of HCV by 2030Henriksen, O. / Christensen, P.B. / Lazarus, J.V. / Awad, T. / Øvrehus, A.L.H. et al. | 2017
- S414
-
Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in FranceWillmington, C. / Ganne-Carrié, N. / Roudot-Thoraval, F. / Leroy, V. / Fontaine, H. / Canva-Delcambre, V. / Larrey, D. / Pol, S. / Mathurin, P. / Yazdanpanah, Y. et al. | 2017
- S415
-
Prevalence of end of life criteria in patients with liver disease in South West EnglandThalheimer, U. / Giannelli, V. et al. | 2017
- S416
-
Long-term disease progression in chronic hepatitis B Chinese patients with comorbid nonalcoholic fatty liver diseaseFan, J.G. / Chen, G.F. / Ji, D. / Ye, D.W. / Wang, C. / Shao, Q. / Li, F. / Li, B. / Wu, V. / Wong, A. et al. | 2017
- S417
-
Steatohepatitis: differential features on quantitative liver-spleen scanHoefs, J.C. et al. | 2017
- S418
-
Hepatic steatosis in an adult population: stronger correlation with the presence of obesity and insulin resistance than with the dietary pattern. Results from a cross-sectional studyLeitão, J. / Cochicho, J. / Carvalhana, S. / Velasco, F. / Silva, A. / Medeiros, I. / Alves, A.C. / Bourbon, M. / Oliveiros, B. / Rodrigues, V. et al. | 2017
- S419
-
The COMMANDS study: improving community-based diagnosis and management of non-alcoholic fatty liver diseaseBurke, L. / Williams, B. / Mann, V. / Wong, L.L. / Corless, L. / Abouda, G. et al. | 2017
- S420
-
Presarcopenia is associated with non-alcoholic fatty liver disease (NAFLD) in older women: the Rotterdam StudyAlferink, L.J.M. / Trajanoska, K. / Schoufour, J.D. / Taimr, P. / Ikram, A.M. / Janssen, H.L.A. / Metselaar, H.J. / Rivadeneira, F. / Murad, S.D. et al. | 2017
- S421
-
NAFLD as an indication for liver transplantation in the Nordic countries – a cohort study during 1982-2015Holmer, M. / Melum, E. / Isoniemi, H. / Ericzon, B.-G. / Castedal, M. / Nordin, A. / Schultz, N.A. / Rasmussen, A. / Line, P.-D. / Stål, P. et al. | 2017
- S422
-
Exploring the patient perceived impact of non-alcoholic steatohepatitisDoward, L.C. / Balp, M.-M. / Stewart, K.E. / Cryer, D. / Langford, A. / Twiss, J. / Agashivala, N. / Brass, C.A. / Anstee, Q.M. / Sanyal, A. et al. | 2017
- S423
-
Nonalcoholic fatty liver with hepatic arterial buffer response strongly caused metabolic diseases, while bright pancreas was not associated with metabolic diseases – 5 years’ cohortHirooka, M. / Koizumi, Y. / Miyake, T. / Yukimoto, A. / Nakamura, Y. / Imai, Y. / Watanabe, T. / Yoshida, O. / Tokumoto, Y. / Abe, M. et al. | 2017
- S424
-
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patientsLemoine, M. / Lacombe, K. / Bastard, J.-P. / Fonquernie, L. / Sébire, M. / Fellahi, S. / Valin, N. / Capeau, J. / Girard, P.-M. / Meynard, J.-L. et al. | 2017
- S425
-
SAF score effectively identifies NAFLD subjects at high risk of subsequent liverrelated but not cardiovascular or malignancy-associated mortality and morbidityStrasser, M. / Feldman, A. / Schranz, M. / Stechemesser, L. / Denkmayr, L. / Ruhaltinger, S. / Strebinger, G. / Huber-Schönauer, U. / Niederseer, D. / Zandanell, S. et al. | 2017
- S426
-
Effect of a probiotic on fatty liver index and liver stiffness in NAFLD patients: randomized clinical trialKobyliak, N. / Bosak, N. / Falalyeyeva, T. / Beregova, T. / Bodnar, P. et al. | 2017
- S428
-
Natural history of patients with NASH followed at a tertiary referral liver center: impact of presenting features.Mantry, P.S. / Mehta, A.P. / Kumar, A. / Weinstein, J.S. / Nazario, H. / Pagadala, M. / Barnes, M. / Habib, A. et al. | 2017
- S429
-
Hepatocyte nuclear factor 4α played a different role in lipotoxicity and bile acid toxicity in non-alcoholic fatty liver disease modelLee, J.S. / Jun, D.W. / Ahn, S.B. / Saeed, W.K. / Chae, Y.J. / Jeong, J.Y. / Kang, H.T. / Sohn, J.H. / Jang, E.C. / Kang, B.-K. et al. | 2017
- S431
-
Obeticholic acid improves histological, biochemical and gene expression profiles in Gubra AMLN mice with biopsy-confirmed NASHRoth, J. / Feigh, M. / Veidal, S. / Rigbolt, K. / Young, M. et al. | 2017
- S432
-
New GLP-1 agonist dulaglutide improves metabolic dysfunction and extenuates development of non-acoholic steatohepatitis in miceHupa, K.L. / Hardtke-Wolenski, M. / Manns, M.P. / Jaeckel, E. et al. | 2017
- S433
-
Increased non-shivering thermogenesis had preventive but no therapeutic effects on non-alcoholic steatohepatitisPoekes, L. / Horsmans, Y. / Farrell, G. / Leclercq, I.A. et al. | 2017
- S435
-
Novel PCR-based method to detect fungal colonization of ascites, bile and duodenal fluid in patients with acute on chronic liver failure (ACLF) or after orthotope liver transplantation (OLT)Herber, A. / Engelmann, C. / Krohn, S. / Zeller, K. / Müller, N.F. / Petros, S. / Bercker, S. / Laudi, S. / Hoffmeister, A. / Berg, T. et al. | 2017
- S436
-
Model for end stage liver disease score dynamics in patients awaiting liver transplantation and waitlist outcomesMannalithara, A. / Chan, J.L. / Hagerty, D. / Kim, W.R. et al. | 2017
- S437
-
The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantationLattanzi, B. / Ledda, R. / Di Gregorio, V. / Galli, A.M. / Mennini, G. / D’Ambrosio, D. / Rossi, M. / Corradini, S.G. / Attilia, M.L. / Merli, M. et al. | 2017
- S439
-
Preoperative intra-platelet serotonin levels are associated with early disease recurrence after liver resection in humansPereyra, D. / Padickakudy, R. / Haegele, S. / Offensperger, F. / Oehlberger, L. / Schwarz, C. / Assinger, A. / Brostjan, C. / Gruenberger, T. / Starlinger, P. et al. | 2017
- S440
-
Leaky gut does not affect the risk of infectious complications and survival in liver transplant recipients: comparison with cirrhotic patients and healthy individualsPonziani, F.R. / Valenza, V. / Lorusso, M. / Carvelli, M.E. / Paone, R. / Siciliano, M. / Avolio, A.W. / Grieco, A. / Agnes, S. / Gasbarrini, A. et al. | 2017
- S442
-
Laparoscopic liver resection for hepatocellular carcinoma located in segments 7 or 8Guro, H. / Cho, J.Y. / Jang, J.S. / Choi, Y. / Kim, H. / Kim, S. / Kwon, S.U. et al. | 2017
- S443
-
Impact of sustained virological response to interferon therapy for chronic hepatitis C on recurrence and long-term survival in patients with hepatocellular carcinomaShinkawa, H. / Hasegawa, K. / Arita, J. / Akamatsu, N. / Kaneko, J. / Sakamoto, Y. / Kokudo, N. et al. | 2017
- S444
-
Risk of hepatocellular carcinoma recurrence is changing according to serial liver stiffness measurement follow-up in patients who underwent radiofrequency ablation for hepatocellular carcinomaKim, H. / Kwon, S. / Lee, J. / Yoon, J. / Lee, Y. / Kweon, Y. / Tak, W. / Park, S. / Jang, S. / Hur, K. et al. | 2017
- S445
-
Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVACMayer, A. / Accolla, R. / Ma, Y.T. / Heidenreich, R. / Koenigsrainer, A. / Izzo, F. / Loeffler, M. / Flohr, C. / Mueller, P. / Kutscher, S. et al. | 2017
- S446
-
Conditional probability of long-term survival in patients with locally advanced and metastatic hilar cholangiocarcinomaGaspersz, M. / Buettner, S. / van Vugt, J. / Roos, E. / Coelen, R. / van Gulik, T. / IJzermans, J. / Koerkamp, B.G. et al. | 2017
- S447
-
Black hepatocellular carcinoma patients diagnosed after 2010 have worse long-term survival than white patientsEstevez, J. / Yang, J.D. / Leong, J. / Nguyen, P. / Giama, N. / Roberts, L. / Schwartz, M. / Nguyen, M. et al. | 2017
- S448
-
Functional health literacy can affect patient perception for the need for liver imaging for HCC screeningShaw, J. / Patidar, K. / Dharel, N. / Driscoll, C. / Heuman, D. / Bajaj, J.S. et al. | 2017
- S449
-
The risk of hepatitis B virus reactivation is considerably high during sorafenib therapy in patients with advanced hepatocellular carcinomaSuh, S.J. / Yim, H.J. / Seo, J.H. / Lee, Y.S. / Hyun, J.J. / Jung, Y.K. / Kim, J.H. / Seo, Y.S. / Yeon, J.E. / Byun, K.S. et al. | 2017
- S450
-
Neuroligin4 over expression on natural killer cells cause their impairment in patients with cirrhosis and hepatocellular carcinomaAmer, J. / Salhab, A. / Khalieleh, H. / Safadi, R. et al. | 2017
- S451
-
Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatmentBruix, J. / Merle, P. / Granito, A. / Huang, Y.-H. / Bodoky, G. / Pracht, M. / Yokosuka, . / Rosmorduc, O. / Breder, V. / Gerolami, R. et al. | 2017
- S452
-
Improved prediction of survival by a risk factor-integrated inflammatory score in Sorafenib treated hepatocellular carcinomaSprinzl, M.F. / Koch, S. / Seib, M.L. / Weinmann-Menke, J. / Lang, H. / Zöller, D. / Marquardt, J.U. / Wörns, M.-A. / Galle, P.R. / Weinmann, A. et al. | 2017
- S453
-
Validation of the ALBI grade as a substitute for the Child-Pugh class in the BCLC classification of hepatocellular carcinoma and of the additional value provided by the Neutrophil-to-Lymphocyte RatioColombo, M. / Burlone, M.E. / Minh, M.T. / Minisini, R. / Giarda, P. / PInato, D.J. / Pirisi, M. et al. | 2017
- S454
-
External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: a multicenter cohort studyBorzio, M. / Dionigi, E. / Rossini, A. / Marignani, M. / Sacco, R. / De Sio, I. / Bertolini, E. / Francica, G. / Giacomin, A. / Parisi, G. et al. | 2017
- S455
-
Treatment patterns and clinical outcomes for patients with hepatocellular carcinoma from China: a sub-analysis of the Global Hepatocellular Carcinoma BRIDGE StudyChen, M. / Li, L. / Li, H. / Zhang, Y. / Wang, F. / Yan, L. / Bai, Y. / Han, G. / Hu, H. / Qin, S. et al. | 2017
- S456
-
PET/CT findings using 18F-labeled galactose tracer (FDGal) vs. 18F-labeled glucose tracer (FDG) in patients with hepatocellular carcinomaBak-Fredslund, K.P. / Kramer, S. / Villadsen, G.E. / Keiding, S. / Sørensen, M. et al. | 2017
- S457
-
Analysis of the breath metabolome in patients with Hepatocellular carcinomaRifai, G. / Hammad, A. / Elshamy, M. / Mehta, N. / Grove, D. / Lopez, R. / Aucejo, F. / Alkhouri, N. et al. | 2017
- S459
-
Effect of novel AKT inhibitor ARQ 751 as single agent and its combination with sorafenib on hepatocellular carcinoma in a cirrhotic rat modelKeerthi, K. / Jilkova, Z.M. / Roth, G.S. / Abbadessa, G. / Yu, Y. / Marche, P. / Decaens, T. et al. | 2017
- S460
-
PNPLA3 p.I148M risk allele carriers might be at-risk of chemotherapy-associated steatohepatitis (CASH)Casper, M. / Zimmermann, S. / Lammert, F. / Krawczyk, M. et al. | 2017
- S461
-
Hepatocyte nanodelivery using siRNA c-Jun N-terminal Kinase-2 (siJnk2) for the treatment of chronic liver diseaseWoitok, M.M. / Doleschel, D. / Zoubek, M.E. / Kiessling, F. / Lederle, W. / Trautwein, C. / Cubero, F.J. et al. | 2017
- S462
-
Genetic and epigenetic bases of the relationship between reduced OCT1 expression and poor response to sorafenib in hepatocellular carcinoma and cholangiocarcinomaAl-Abdulla, R. / Lozano, E. / Macias, R.I. / O’Rourke, C.J. / Perez, M.J. / Serrano, M.A. / Romero, M.R. / Monte, M.J. / Herraez, E. / Briz, O. et al. | 2017
- S464
-
Extracellular ATP and subsequent purinergic P2Y2 receptor signalling promote liver tumorigenesis in miceSchulien, I. / Hockenjos, B. / Hasselblatt, P. et al. | 2017
- S465
-
Molecular characterization of the immune class of hepatocellular carcinomaMartinez-Quętglas, I. / Sia, D. / Jiao, Y. / Kuchuck, O. / Martin, C.V. / De Moura, M.C. / Putra, J. / Camprecios, G. / Thung, S. / Mazzaferro, V. et al. | 2017
- S466
-
Characterization of cancer associated fibroblasts in primary site and metaststic lymph nodes of intrahepatic cholangiocarcinoma by immunohistochmistryUyama, N. / Kawada, N. / Hirota, S. / Hatano, E. / Fujimoto, J. et al. | 2017
- S467
-
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenibCho, H.J. / Kim, S.S. / Cho, S.W. / Cheong, J.Y. et al. | 2017
- S468
-
Prevalence and risk factors for hepatitis B infection in the adult population of Georgia: a nationwide surveyKasradze, A. / Kuchukhidze, G. / Baliashvili, D. / Salyer, S. / Gamkrelidze, A. / Tsereteli, M. / Chitadze, N. / Alkhazashvili, M. / Zakhashvili, K. / Drobeniuc, J. et al. | 2017
- S469
-
Prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disordersParfieniuk-Kowerda, A. / Pogorzelska, J. / Lapinski, T.W. / Maciaszek, M. / Swiderska, M. / Grzeszczuk, A. / Naumnik, B. / Rowiński, M. / Jaroszewicz, J. / Flisiak, R. et al. | 2017
- S470
-
Clinical outcomes were comparable between chronic hepatitis B patients with virological response using oral antiviral therapy and inactive carriers when adjusting for fibrotic burdenKim, B.K. / Kim, H.S. / Kim, S.U. / Park, J.Y. / Kim, D.Y. / Ahn, S.H. / Song, K.J. / Han, K.-H. et al. | 2017
- S471
-
2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizing ribavirinQu, C. / Wang, W. / Xu, L. / Yin, Y. / Pan, Q. / Peppelenbosch, M. et al. | 2017
- S473
-
Characterization and evaluation of hepatic fibrosis degree in patients with chronic hepatitis B virus infection with normal transaminasesJuan, C.S. / Casado, M. / Gonzalez, M. / Hallouch, S. / Práxedes, E. / Porcel, A. / Gálvez, A. / Anguita, F. / Vega, J.L. et al. | 2017
- S474
-
The value of subtyping genotype A in chronic hepatitis B: differences in disease course and implications for therapyGonsalkorala, E. / Bruce, M. / Horner, M. / Wang, B. / Carey, I. / Agarwal, K. et al. | 2017
- S475
-
Low viremic HBeAg negative HBsAg carriers: clinical outcome and non invasive diagnostic accuracy for chronic hepatitis B or inactive infection by combinations of HBV markersOliveri, F. / Surace, L. / Cavallone, D. / Colombatto, P. / Ricco, G. / Salvati, N. / Coco, B. / Romagnoli, V. / Gattai, R. / Salvati, A. et al. | 2017
- S477
-
No changes in the coding sequence for HBV core protein after 6 weeks of treatment of HBV infected humanized mice with NVR 3-778Lam, A.M. / Shimada, T. / Dandri, M. / Flores, L. / Klumpp, K. et al. | 2017
- S478
-
Characterization of the intrahepatic immune response of virally-suppressed chronic hepatitis B patients to treatment with the oral TLR7 agonist GS-9620Boeijen, L. / van Oord, G.W. / Hou, J. / van Campenhout, M.J. / van der Heide-Mulder, M. / Gaggar, A. / Li, L. / Fletcher, S.P. / de Knegt, R.J. / Boonstra, A. et al. | 2017
- S479
-
Serum HBV RNA level monitoring for response prediction in HBeAg positive chronic hepatitis B infectionvan Campenhout, M.J. / van Bömmel, F. / Grossmann, M. / Fischer, J.J. / Deichsel, D. / Boonstra, A. / van Vuuren, A.J. / Berg, T. / Hansen, B.E. / Janssen, H.L. et al. | 2017
- S480
-
Altered expression of interferon-stimulated genes is strongly associated with therapeutic outcomes in hepatitis B virus infectionHan, M. / Li, Y. / Wu, W. / Zhang, Y. / Yan, W. / Luo, X. / Ning, Q. et al. | 2017
- S481
-
Quantification of serum hepatitis B core-related antigen to understanding the hepatitis B virus and hepatitis D virus chronic infectionRuiz-Ripa, A. / Riveiro-Barciela, M. / Tabernero, D. / Godoy, C. / Sopena, S. / López-Martínez, R.M. / Buti, M. / Rodríguez-Frías, F. et al. | 2017
- S482
-
Increased hepatitis B virus (HBV) specific IFN-γ and IL17A secretion by T cell subsets in HBV infected non transmitting mothers and their HBV negative new-borns: a Novel mechanism for prevention of HBV vertical transmissionVyas, A.K. / Patra, S. / Islam, M. / Sarin, S.K. / Trehanpati, N. et al. | 2017
- S483
-
Hepatitis B virus quasispecies complexity is lower in hepatitis B virus–hepatitis D virus infection than in hepatitis B virus monoinfectionGodoy, C. / Sopena, S. / Gregori, J. / Tabernero, D. / Homs, M. / Casillas, R. / Ruiz, A. / Riveiro-Barcela, M. / Quer, J. / Esteban, R. et al. | 2017
- S484
-
Proteomic profiling of plasma proteins associated with spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis BLiu, F. / Seto, W.-K. / Wong, D.K.-H. / Sharma, R. / Huang, F.-Y. / Cheung, K.-S. / Fung, J. / Lai, C.-L. / Yuen, M.-F. et al. | 2017
- S485
-
The NLRP3 inflammasome is activated in liver tissue of patients with newly diagnosed chronic hepatitis B virus infectionGermanidis, G. / Molyvdas, A. / Loli, G. / Hytiroglou, P. / Vassiliadis, T. / Lazaridis, N. / Morfesis, P. / Zebekakis, P. / Germenis, A.E. / Speletas, M. et al. | 2017
- S486
-
Prediction for the incidence of hepatocellular carcinoma in patients with chronic hepatitis B after administration of nucleos(t)side analogTakahashi, H. / Okuse, C. / Yamada, N. / Niinuma, T. / Yamamoto, E. / Kai, M. / Wakasugi, H. / Akutsu, N. / Yotsuyanagi, H. / Suzuki, M. et al. | 2017
- S487
-
HBV/HDV co-infection microRNA profile: downregulation of anti-inflammatory and upregulation of pro-apoptotic and viral replication mircoRNAs is associated with HDV RNA replication and HBsAg levelsCarey, I. / Shang, D. / Bruce, M. / Horner, M. / Subramanian, M. / Gaggar, A. / Agarwal, K. et al. | 2017
- S489
-
Integrated healthcare system implementation of one time hepatitis C virus testing for patients born between 1945 and 1965 with linkage to careLevin, J.M. / Huckins, E. et al. | 2017
- S490
-
Linkage to care of HBsAg and anti-HCV positive patients after a systematic screening approach in the German primary care settingLüllau, A. / Petroff, D. / Bätz, O. / Kramer, J. / Jedrysiak, K. / Tenckhoff, H. / Berg, T. / Wolffram, I. / Wiegand, J. et al. | 2017
- S491
-
Sustained viral response following treatment with direct acting antiviral agents for chronic hepatitis C and the risk of hepatocellular carcinomaReddy, K.R. / Bourliere, M. / Agarwal, K. / Lawitz, E. / Osinusi, A. / Kersey, K. / Crans, G. / Moody, S. / Ni, L. / Brainard, D.M. et al. | 2017
- S492
-
Drug-drug interaction profile of sofosbuvir/velpatasvir/ voxilaprevir fixed-dose combinationGarrison, K.L. / Kirby, B. / Stamm, L.M. / Ma, G. / Vu, A. / Ling, J. / Mathias, A. et al. | 2017
- S493
-
Long-term fibrosis improvement after sustained virologic response in patients with chronic hepatitis C and advanced fibrosis or cirrhosis – pre-treatment cirrhosis, older age and high body mass index increases the risk for persisting fibrosisHedenstierna, M. / Nangarhari, A. / Weiland, O. / Aleman, S. et al. | 2017
- S494
-
An approach to hepatitis C Virus epidemiology: analysis in 7602 patients of orthopaedic surgeryPipa-Muniz, M. / Romero, M.I. / Alonso, E.B. / Luengo, M.C. / Trastoy, P.V. / Mata, A.M. / Franco, L. / López, R.G. / Ruiz, E.F. / Muñiz, I.P. et al. | 2017
- S495
-
DAA treatment scale-up in HIV/HCV co-infection: characterisinga population at risk for reinfectionMartinello, M. / Dore, G.J. / Bopage, R.I. / Finlayson, R. / Baker, D. / Bloch, M. / Wilcox, A. / Filep, E. / Hellard, M. / Matthews, G.V. et al. | 2017
- S496
-
Association between improved liver function and selenium depends on C718T polymorphism in 3’- untranslated region of glutathione peroxidase 4 and in humansRohr-Udilova, N. / Theiner, S. / Beinhardt, S. / Stättermayer, A. / Scherzer, T. / Seif, M. / Köllensperger, G. / Keppler, B. / Eder, E. / Willheim, C. et al. | 2017
- S499
-
Epidemiology and treatment of hepatitis C virus infection in China in 2013–2015: a hospital-based population studyChen, Z.-W. / Liu, B. / Li, Z. / Li, H. / Ren, H. / Hu, P. et al. | 2017
- S500
-
A novel single daily fixed dose combination of sofosbuvir 400 mg + ribavirin1000 mg + EGCG 400 mg is superior to the standard of care as an anti-viral and safer causing less hemolysis in patients with chronic hepatitis CShiha, G. / Soliman, R. / Mousa, A. / Mousa, S. et al. | 2017
- S501
-
Rapid liver fibrosis regression after sustained virological response in HCV patients treated with direct acting antiviralsLledó Ibáñez, G.M. / Arias, A. / Benítez-Gutiérrez, L.M. / Cítores, M.J. / Carrasco, I. / Cuervas-Mons, V. / De Mendoza, C. et al. | 2017
- S502
-
An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapyBrancaccio, G. / Sorbo, M.C. / Frigeri, F. / Rizzo, V. / Cantone, M. / Genderini, F. / Fabeni, L. / Pinto, A. / Perno, C.F. / Ceccherini-Silberstein, F. et al. | 2017
- S503
-
Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: final results of the C-ISLE studyFoster, G.R. / Agarwal, K. / Cramp, M.E. / Moreea, S. / Barclay, S. / Collier, J. / Brown, A.S. / Ryder, S.D. / Ustianowski, A. / Forton, D.M. et al. | 2017
- S504
-
Successful treatment of patients with HCV GT3 infection and cirrhosis with elbasvir/grazoprevir plus sofosbuvir does not correct insulin resistance by 12 weeks post-treatmentFoster, G. / Agarwal, K. / Cramp, M.E. / Moreea, S. / Barclay, S. / Collier, J. / Brown, A.S. / Ryder, S.D. / Ustianowski, A. / Forton, D.M. et al. | 2017
- S505
-
Modeling vaccine and DAA treatment scale up effect on hepatitis C prevalence among persons who inject drugs in metropolitan ChicagoEchevarria, D. / Gutfraind, A. / Boodram, B. / Cotler, S.J. / Major, M. / Dahari, H. et al. | 2017
- S506
-
Full dose, daily sofosbuvir treatment in end-stage renal disease: tolerability & safety of largest ESRD patient cohort exposed to this drugNazario, H.E. / Modi, A.A. / Ndungu, M. / Ramirez, R. / Tujague, L. / Weinstein, J.S. et al. | 2017
- S507
-
Impact of directly acting antiviral drugs during treatment of decompensated cirrhosis with chronic hepatitis CNayak, H.K. / Kumar, K. / Pande, G. / Mohindra, S. / Saraswat, V.A. et al. | 2017
- S508
-
Ribavirin free versus Ribavirin containing therapy with all second generation direct acting antivirals for the treatment of hepatitis C virus genotype 1 infection; a pooled analysis of 4501 patientsAhmed, H. / Abushouk, A.I. / Menshawy, A. / Attia, A. / Negida, A. / Loutfy, S.A. et al. | 2017
- S509
-
Response guided addition of Sofosbuvir to pegylated interferon and ribavirin cures greater than 90% of patients with Genotype 3 infection and F0–2 diseaseHay, I. / Cairns, H. / Fox, R. / Datta, S. / Barclay, S.T. et al. | 2017
- S510
-
Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily RegistryCacciola, I. / Petta, S. / Di Stefano, M. / Cannavò, M.R. / Davì, A. / Madonia, S. / Calvaruso, V. / Rocca, L.L. / Di Lorenzo, F. / Digiacomo, A. et al. | 2017
- S511
-
Relapse post DAA therapy: are we too focussed on RAV and neglecting ribavirin?Carey, I. / Cannon, M. / Verma, S. / Bruce, M. / Childs, K. / Considine, A. / Agarwal, K. et al. | 2017
- S512
-
Projection of patients who fail treatment in the era of direct-acting antiviralsChhatwal, J. / Chen, Q. / Ayer, T. / Kanwal, F. / Wang, X. / Roberts, M.S. / Fagiuoli, S. / Petersen, J. et al. | 2017
- S513
-
SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapyGrebely, J. / Jacobson, I.M. / Kayali, Z. / Verna, E.C. / Shiffman, M.L. / Hyland, R.H. / Stamm, L.M. / Huang, K.C. / Brainard, D.M. / McHutchison, J.G. et al. | 2017
- S514
-
HepCom: impact of co-morbidities on the final success of direct antiviral agents therapy in hepatitis CAmpuero, J. / Maté, C.J. / Quiles, R. / Palomo, N. / Rosales, J.M. / Llerena, S. / Cordero, P. / Serrano, F.J. / Urquijo, J.J. / Maraver, M. et al. | 2017
- S515
-
Analysis of the real-world treatment effectiveness of elbasvir/grazoprevirMc Combs, J.S. / McGinnis, J. / Fox, S. / Tonnu-Mihara, I. et al. | 2017
- S517
-
Changes in markers of liver function in hepatitis C virus genotype 1b Asian patients with compensated cirrhosis treated with ombitasvir/paritaprevir/ritonavir plus dasabuvir with ribavirin in the ONYX-II studyHeo, J. / Luo, Y. / Chuang, W.-L. / Jia, J. / Han, K.-H. / Yu, M.-L. / Tang, H. / Lim, Y.-S. / Peng, C.-Y. / Xu, M. et al. | 2017
- S518
-
Total cholesterol and low-density lipoprotein increases after treatment with direct-acting antiviral agents – Implications in the future?Carvalho, J.R.O.A.S. / Serejo, F. / Velosa, J. et al. | 2017
- S519
-
Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)Vermehren, J. / Athmann, C. / Günther, R. / Schott, E. / Pathil, A. / Boeker, K.H. / Cornberg, M. / Niederau, C. / Simon, K.-G. / Maasoumy, B. et al. | 2017
- S520
-
Efficacy and safety of Simeprevir-containing hepatitis C therapy in patients on opiate substitution therapyDillon, J. / Mauss, S. / Nalpas, C. / Bicer, C. / Schlag, M. / Lonjon-Domanec, I. / Jessner, W. / Beumont-Mauviel, M. / Kalmeijer, R. et al. | 2017
- S521
-
Impact of elbasvir/grazoprevir (EBR/GZR) on health-related quality of life (HRQOL) and fatigue in patients with chronic hepatitis C virus (HCV) infection and inherited blood disorders (IBLD): data from the C-EDGE IBLD studyVierling, J.M. / Sobhonslidsuk, A. / Papatheodoridis, G. / Assy, N. / Rosenberg, W. / Guyader, D. / Dev, A. / Gordon, S.C. / Pol, S. / Luketic, V.A. et al. | 2017
- S522
-
Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antiviralsRuiz-Antorán, B. / Rincón, D. / Perelló, C. / Fernandez, I. / Gea, F. / Mariño, Z. / García-Samaniego, J. / Hontangas, V. / Cabezas, J. / Sacristan, B. et al. | 2017
- S523
-
Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practiceRuiz-Antorán, B. / Rincón, D. / Conde, M.H. / Fernández, I. / García-Samaniego, J. / Gea, F. / Cabezas, J. / Sacristán, B. / Jorquera, F. / Turnes, J. et al. | 2017
- S524
-
Suitability of HCV treatment in primary care settings for individuals with HIV/hepatitis C coinfectionDoyle, J.S. / Bowring, A.L. / Iser, D.M. / Sasadeusz, J. / Roney, J. / O’Reilly, M. / Fairley, C. / Gane, E. / Hoy, J. / Matthews, G.V. et al. | 2017
- S526
-
Efficacy of therapy against chronic hepatitis C virus genotype 1 infection in HIV-coinfected patients with several interferon-free DAA combinations: real life data from the HEPAVIR-DAA CohortNeukam, K. / Téllez, F. / Morano-Amado, L.E. / Rivero-Juárez, A. / Nuño-Álvarez, E. / Ríos, M.J. / Macías, J. / Merino, D. / Pérez-Pérez, M. / Pineda, J.A. et al. | 2017
- S528
-
Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemiaDiakite, M. / Hartig-Lavie, K. / Miailhes, P. / Pradat, P. / Uhrés, A.-C. / Zoulim, F. / Sarda, M.-N. et al. | 2017
- S529
-
Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6)Agarwal, K. / Brown, R.S. / Dumas, E.O. / McCaughan, G.W. / Samuel, D. / Terrault, N. / Brown, K.A. / Mantry, P.S. / Berenguer, M. / Kwo, P.Y. et al. | 2017
- S531
-
Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patientsWei, L. / Luo, Y. / Chuang, W.-L. / Paik, S.W. / Yu, M.-L. / Fredrick, L.M. / Campbell, A. / Trinh, R. / Enejosa, J. / Shulman, N.S. et al. | 2017
- S533
-
In vitro virology profile of the 3 direct-acting antiviral combination of AL-335, odalasvir and simeprevirVijgen, L. / Fevery, B. / Jekle, A. / Shaw, K. / Tan, H. / Lenz, O. / Symons, J. / De Meyer, S. et al. | 2017
- S534
-
Decrease of Interleukin-6 and Interleukin-8 blood levels after successful interferon-free anti-HCV treatmentBadia, L. / Rinaldi, M. / Assirelli, C. / Rossi, N. / Guardigni, V. / Viale, P. / Verucchi, G. et al. | 2017
- S535
-
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)Kondili, L.A. / Di Leo, A. / Iannone, A. / Santantonio, T. / Giammario, A. / Raimondo, G. / Filomia, R. / Coppola, C. / Amoruso, D. / Blanc, P. et al. | 2017
- S536
-
The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV NetworkPasulo, L. / Aghemo, A. / Fargion, S. / Spinetti, A. / Cologni, G. / Maggiolo, F. / Rizzardini, G. / Puoti, M. / Bruno, R. / Minoli, L. et al. | 2017
- S537
-
Hepatitis E virus-specific T cell responses against non-structural viral proteins in patients with ongoing and resolved hepatitis EAl-Ayoubi, J. / Behrendt, P. / Bremer, B. / Gisa, A. / Rinker, F. / Manns, M.P. / Cornberg, M. / Wedemeyer, H. / Kraft, A.R.M. et al. | 2017
- S538
-
Comprehensive immune changes associated with HCV direct-acting antiviral curesSlauenwhite, D. / Arseneault, K. / Brisseau, C. / Oldford, S. / Barrett, L. et al. | 2017
- S539
-
KLRG1 impairs antiviral immunity of NK-cell in Individuals with Chronic Hepatitis B Virus Infection via the Akt pathwayLi, M.-H. / Yin, W.-W. / Zhang, Q.-F. / Liu, Q. / Li, Y.-L. / Shao, J.-Y. / Hu, H.-D. / Ren, H. / Hu, P. / Zhang, D.-Z. et al. | 2017
- S541
-
Myeloid-Derived Suppressor Cells: key players mediating immunosuppression via induction of Regulatory T-cell by TGFβ and IL-10 driven pathways in chronic HBV infectionPal, S. / Nandi, M. / Dey, D. / Ahammed, S.M. / Banerjee, S. / Santra, A. / Chowdhury, A. / Datta, S. et al. | 2017
- S543
-
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death in different age-categories over timeGoet, J.C. / Lammers, W.J. / Floreani, A. / Pares, A. / Janssen, H.L.A. / Hirschfield, G.M. / Van Buuren, H.R. / Corpechot, C. / Invernizzi, P. / Lindor, K.D. et al. | 2017
- S544
-
Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumabWilliamson, K.D. / Slevin, S. / Willberg, C. / Chapman, R. / Klenerman, P. / Keshav, S. et al. | 2017
- S545
-
The interpretation of follow-up 3D-magnetic resonance cholangiopancreatography/magnetic resonance imaging in patients with primary sclerosing cholangitis is difficult and highly variable even between experienced specialistsZenouzi, R. / Yamamura, J. / Keller, S. / Weiler-Normann, C. / Sebode, M. / Lohse, A.W. / Schramm, C. et al. | 2017
- S546
-
Health related quality of life (HRQoL) in patients with AIH: a prospective, single centre studyKruk, B. / Janik, M.K. / Raszeja-Wyszomirska, J. / Krawczyk, M. / Milkiewicz, P. et al. | 2017
- S547
-
Dynamic risk prediction in Primary Biliary Cholangitis using the UK-PBC cohortCarbone, M. / Nardi, A. / Ainsworth, H. / Heneghan, M.A. / Hirschfield, G.M. / Thorburn, D. / Bathgate, A. / Aldersley, M. / Neuberger, J.M. / Stocken, D. et al. | 2017
- S548
-
Non-invasiveevaluationofliverfibrosisinautoimmunehepatitis: still a challengeFerraz, M.L.C.G. / Oliveira, E. / Perez, R.M. / Dellavance, A.L.C.G. / Andrade, L.E. / Lanzoni, V.P. et al. | 2017
- S549
-
Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody positive subjectsZandanell, S. / Feldman, A. / Denkmayr, L. / Strasser, M. / Ruhaltinger, S. / Strebinger, G. / Huber-Schönauer, U. / Niederseer, D. / Stechemesser, L. / Paulweber, B. et al. | 2017
- S550
-
Tolerability and efficacy of 6-mercaptopurin in patients with autoimmune liver disease and azathioprine intoleranceElnegouly, M. / Kraus, M.R. / Zoller, H. / Umgelter, A. / Geisler, F. et al. | 2017
- S551
-
Geoepidemiology, clinical manifestations and outcome of a large cohort of primary biliary cholangitis patients in GreeceGatselis, N.K. / Zachou, K. / Lygoura, V. / Azariadis, K. / Arvaniti, P. / Spyrou, E. / Papadamou, G. / Koukoulis, G.K. / Dalekos, G.N. / Rigopoulou, E.I. et al. | 2017
- S553
-
T cell interactions with the biliary epithelium in primary biliary cholangitisEtherington, R.E. / Millar, B. / Innes, B. / Brain, J. / Kirby, J. / Jones, D. et al. | 2017
- S554
-
The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosisKummen, M. / Holm, K. / Vesterhus, M. / Trøseid, M. / Melum, E. / Aukrust, P. / Karlsen, T.H. / Hov, J.R. et al. | 2017
- S555
-
Expression of the bile acid receptor TGR5 in livers of PSC patients and Mdr2-/- (Abcb4-/-) miceReich, M. / Spomer, L. / Hoehne, J. / Hov, J.E. / Karlsen, T.H. / Nierhoff, D. / Häussinger, D. / Keitel, V. et al. | 2017
- S556
-
Melatonin levels are significantly decreased in liver tissues of patients with Primary Biliary CholangitisWasik, U. / Milkiewicz, P. / Milkiewicz, M. et al. | 2017